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Abstract 
The MacMillan group focuses on the development of new strategies that harness the 
power of simple organic compounds to catalyze asymmetric reactions.  To this end, we 
have designed amine catalysts which activate α,β-unsaturated aldehydes via the reversible 
formation of chiral iminium ions (in analogy to LUMO-lowering activation by reversible 
metal-substrate complexation).  Kinetic studies highlight the importance of the acid co-
catalyst and identified a more reactive imidazolidinone catalyst complex, which improved 
enantioselectivities and vastly expanded the substrate scope of the first highly 
enantioselective organocatalytic Diels–Alder reaction.  Exploration of the crucial 
components of catalyst architecture led to the development of the second-generation 
imidazolidinone that not only catalyzes cycloadditions, but a variety of other reactions of 
aldehydes with excellent selectivity. 
Complementary to the 1,2-addition observed with Lewis acids, the alternative mode of 
activation offered by iminium catalysis allows for 1,4-addition of heterocycles to α,β-
unsaturated aldehydes.  Using a chiral amine catalyst, the first asymmetric conjugate 
addition of oxazoles generates protected quaternary α-amino acids with an adjacent tertiary 
stereocenter, a widely applicable motif in biology, materials science, and medicine.  
Finally, having demonstrated that imidazolidinones can activate both electrophiles (LUMO-
lowering) and nucleophiles (HOMO-raising), these iminium and enamine catalysis cycles 
can be linked for tandem nucleophilic addition/electrophilic trapping of enals.  In a single 
synthetic operation, this enantioselective conjugate addition/α-halogenation sequence takes 
achiral starting materials and selectively connects them, creating multiple stereocenters 
across the newly formed bonds. 
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Chapter 1 
Enantioselective Organocatalytic Diels–Alder Reactions 
 
Introduction 
The demand for single enantiomer molecules for academic and industrial applications 
has propelled asymmetric catalysis to the forefront of investigations in synthetic chemistry.  
Compared to the field of metal-catalyzed asymmetric transformations, one finds a paucity of 
reactions catalyzed by organic molecules despite the attendant advantages in cost, 
operational complexity, time, energy, and elimination of toxic metal wastes.  In recent years, 
there has been a resurgence in the development of enantioselective organocatalytic 
reactions.  A major focus of research in the MacMillan group has become the study of a 
broadly applicable reaction manifold based upon iminium activation using chiral amine 
catalysts.  This report describes investigations aimed at improving the organocatalytic Diels-
Alder reaction developed by our group, a transformation which introduced imidazolidinones 
as flexible catalysts for the activation of unsaturated carbonyl systems.  In order to develop a 
more reactive imidazolidinone catalyst, the reaction components affecting iminium 
formation and reactivity were explored.  Kinetic studies highlight the importance of the acid 
co-catalyst and identified a more reactive complex that improves enantioselectivities and 
vastly expands the substrate scope of this organocatalytic Diels–Alder reaction.  Exploration 
of the catalyst features necessary for reactivity and selectivity led to the development of the 
second-generation imidazolidinone whose high levels of activity are attributed to the 
formation of a more reactive iminium intermediate that not only catalyzes cycloadditions, 
but conjugate additions, hydrogenations, and aldol reactions of aldehydes with excellent 
selectivity. 
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Background 
Since the late 1960s, the field of metal based chiral catalysis has amassed an array of 
enantioselective oxidation, reduction, π-bond activation, and Lewis acid-catalyzed 
reactions.1-5  In contrast, until recently, a limited number of asymmetric reactions employed 
organic molecules as catalysts.6  Ideally, naturally available enantiopure amino acids, 
carbohydrates, and hydroxyl acids could be used directly as catalysts.  The use of robust 
organic catalysts would eliminate the need for air- and moisture-free conditions.  In addition, 
the alternative reactivity of organic molecules may allow for catalysis of transformations 
which are inaccessible via Lewis acid catalysts.  
Interestingly, two of the earliest examples of asymmetric catalytic reactions utilize 
organic systems.  In 1960, the pioneering work of Pracejus presented the first 
enantioselective methanolysis of phenylmethyl ketene using a quinuclidine catalyst (Scheme 
1).7  In the early 1970s, considerable attention was focused on the proline-catalyzed 
intramolecular aldol commonly termed the Hajos-Parrish reaction (Scheme 1).8  The 
reaction was mostly neglected for over a quarter century until List and coworkers 
demonstrated the first intermolecular variant of this direct aldol protocol.9  While many 
successful forays into the field of organocatalysis have been reported in the past few 
years,10-12 they highlight a common limitation in organocatalysis.  In general, the mechanism 
of activation in each case is amenable only to a singular type of transformation and thus 
demands a different catalyst for each specific reaction (Scheme 1).   
 
 
Scheme 1.  Early examples of metal-free catalysis 
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With this is mind we embarked upon the development of a general organocatalytic 
strategy incorporating design elements from the area of Lewis acid catalysis.  Reversible 
Lewis acid binding forms an equilibrium between an electronically neutral α,β-unsaturated 
aldehyde and more reactive, charged intermediate (eq. 1).  This form of activation lowers the 
energy of the lowest unoccupied molecular orbital (LUMO), making it closer in energy to 
the highest occupied molecular orbital (HOMO).  As the energy difference between these 
two reacting partners is decreased, it becomes more facile for them to overcome the 
energetic barrier that separates them, and consequently, react.  As this LUMO-lowering 
mechanism should apply to any carbogenic system that exists as an equilibrium between a 
relatively electron-rich and electron-deficient state, we envisioned that the corresponding 
equilibrium between an α,β-unsaturated aldehyde and the highly reactive α,β-unsaturated 
iminium ion formed upon condensation with an amine would provide a similarly reactive 
catalytic system (eq. 2). 
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Association of chiral ligands to the Lewis acid allows for differentiation of the two 
prochiral faces of the olefin.  We postulated that the analogous equilibrium between a chiral 
secondary amine and an α,β-unsaturated aldehyde to form a chiral activated iminium ion 
would provide asymmetric LUMO-lowering catalysis, thereby affording an attractive 
platform for the development of a new enantioselective organic catalyst that could be 
utilized for a range of transformations which traditionally employ metal salts (Scheme 1).  
Furthermore, upon condensation of the chiral amine catalyst and the prochiral olefin, the 
α,β-unsaturated iminium ion formed can theoretically participate in multiple reaction 
pathways.  For example, Scheme 1 displays the chiral iminium reacting with either 
cyclopentadiene in a Diels–Alder or with a nucleophile via conjugate addition.  In both 
cases, hydrolysis of the catalyst-bound product frees the catalyst to undergo another cycle. 
Scheme 2.  Versatility of LUMO-lowering iminium catalysis by a chiral amine 
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To our knowledge this iminium-catalysis cycle had not been documented in the literature 
prior to our studies.  However, some related experiments encouraged us to pursue this 
organocatalytic strategy.  First of all, reductive amination demonstrates the selectivity 
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required of LUMO-lowering activation in the rapid reduction of an iminium ion to the 
corresponding alkyl amine in the presence of the aldehyde starting material.13  The 
selectivity of this reaction is key in that only the iminium ion formed from reversible 
condensation of the aldehyde and amine is sufficiently electron deficient to undergo hydride 
reduction.  Secondly, the work of Jung and co-workers in the late 1980s revealed that α,β-
unsaturated iminium ions are significantly more reactive as dienophiles than α,β-unsaturated 
aldehydes, acid chlorides, ketones, nitriles, or esters.14,15  In our chiral amine-catalyzed 
system, the rate acceleration due to the delocalized positive charge would effect the 
enantioselective bond-forming step.  Finally, Grieco and co-workers have clearly 
demonstrated that iminium ions generated under Mannich conditions will undergo aza-
Diels–Alder reactions with electron-rich dienes.16  While this reaction does incorporate the 
amine substrate into the Diels–Alder adduct, it provided strong precedent for the supposition 
that electron-rich substrates will react selectively with an equilibrium concentration of 
iminium ions in preference to unactivated aldehydes.  
 
Development of Organocatalyst 
To test our iminium-activation strategy, we first examined the capacity of (S)-proline 
methyl ester to enantioselectively catalyze the Diels–Alder reaction between (E)-
cinnamaldehyde and cyclopentadiene to provide bicycle 1.17  While exposure of the α,β-
unsaturated aldehyde to diene in the absence of the amine resulted only in recovery of 
starting materials, we were excited to find that the introduction of (S)-proline methyl 
ester•HCl salt in catalytic quantities resulted in formation of bicyclic Diels–Alder adduct 1 
in 48% enantioselectivity (ee) and 81% yield (Table 1, entry 4). 
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Additionally, we were able to demonstrate that this organocatalytic strategy could be 
accomplished with a variety of amino acids.  As revealed in Table 1, amines that incorporate 
a relatively basic nitrogen component are poor catalysts in terms of both reaction efficiency 
and enantioselectivity (entries 1 and 2, 5–21% conversion, 0–10% ee).  In contrast, amines 
that are relatively acidic due to a proximal electron withdrawing group (e.g., α-carbonyl as 
in α–amino acids) provide excellent levels of reaction efficiency (entries 3–6, 100% 
conversion).  In this initial survey of chiral amines, tryptophan-derived catalyst 2 provided 
the best levels of enantiocontrol (entry 6, 65% ee). 
Table 1.  Diels–Alder between cinnamaldehyde and cyclopentadiene with representative 
amine catalysts 
1
10 mol% amine catalyst•HCl
95:5 MeOH:H2O, 23 °C
N
H
OH
NHMe
Me
CO2R
NHMe
N
H
CO2Me
NH
CO2Me
N
H
CO2Me
NHMe
OPh
Ph
CHO
2
catalyst conv. (%)
21
5
100
100
100
100
entry
1
2
3
4
5
6
ee (%)
10
0
35
48
56
65
 
Computational models of iminium ion structures 3 and 4, which arise from the 
condensation of catalyst 2 and crotonaldehyde, delineate the structural features from which 
this selectivity originates (Scheme 2).18  In the case of the cis iminium (3), the indole ring of 
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the catalyst blocks the Si-face of the iminium, leaving the Re-face open for attack (Scheme 
2, MM3-1).  With the trans iminium (4), the Re-face is blocked such that cycloaddition 
occurs from the Si-face (Scheme 2, MM3-2).  This dictates that the asymmetric environment 
associated with each iminium isomer will generate the opposite enantiomeric series.  As 
both cis and trans iminium ion geometries are operational according to energetic 
considerations, the 65% enantioselectivity in favor of (R)-1 is due to the presence of an 
energetic preference for the cis-(R)–producing iminium over the the trans-(S)–producing 
isomer.  Therefore, while the indole moiety may confer complete enantiofacial coverage for 
each geometric isomer, if iminium geometry is not somehow restricted to one isomer, both 
enantiomers of the product will form.  As such, these models indicate that catalysts that 
attain poor levels of iminium geometry control will exhibit diminished enantiocontrol. 
Scheme 3.  Calculated iminium intermediates of tryptophan-derived catalyst 
Imidazolidinone Design Elements   
Based on the experimental findings summarized in Table 1 and the computational 
studies outlined in Scheme 2, we have identified four objectives that should be addressed in 
the development of a highly enantioselective and broadly applicable chiral amine catalyst: i) 
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efficient reaction rates, ii) iminium ion geometry control, iii) enantiofacial discrimination 
controlled by catalyst architecture, and iv) ease of preparation and usage. 
On the basis of these design criteria, we selected 5-benzyl-2,2-dimethyl imidazolidinone 
5 as the target amine catalyst for reaction exploration.19  From a practical viewpoint, the 
hydrochloric acid salt of the imidazolidinone (5•HCl) is readily accessed as a crystalline 
bench stable solid in 200-250 gram quantities (Scheme 3).  The reaction of phenylalanine 
methyl ester with N-methylamine produces the N-methylamide of phenylalanine, which 
upon condensation with acetone and treatment with hydrochloric acid cleanly provides 
5•HCl.   
1.  NH2Me
2.  acetone, HCl
imidazolidinone catalyst
  5•HCl
(S)-Phenylalanine methyl ester
N
N
H •HCl
O Me
Me
Me
Ph
OMe
O
NH2
Ph
(3)
 
This imidazolidinone system (5•HCl) was expected to readily condense with an α,β-
unsaturated aldehyde such as crotonaldehyde to form iminium 6.  In terms of catalyst 
architecture, the amide carbonyl acidifies the secondary ammonium of 5•HCl to allow 
aldehyde protonation while the five-membered ring enhances the nucleophilicity of the 
resultant amine for condensation with the protonated aldehyde.  As the catalyst is an organic 
molecule as opposed to an organometallic system, it is straightforward to conduct molecular 
modeling experiments to determine the most energetically favorable conformation of the 
chiral iminium (6).  The expectation for significant levels of asymmetric induction from 
intermediate 6 was based upon the calculated iminium ion model MM3-3 (Scheme 3).  
Inspection of structure MM3-3 reveals two salient stereocontrol elements: (i) selective 
formation of the trans-iminium isomer to avoid non-bonding interactions between the 
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substrate olefin and the geminal methyl substituents and (ii) shielding of the Si-face of the 
dienophile by the benzyl group on the catalyst framework.  This leaves the Re-face exposed 
for enantioselective bond formation such that the (2R)-cycloadduct is expected in the 
cycloaddition of cyclopentadiene with iminium 6.  
Figure 1.  Calculated iminium intermediates of benzyl imidazolidinone catalyst   
N
N
O Me
Me
Me
Ph
H
Me
6
Re-face Me
CHO
predict  2R
MM3–3
i) efficient reaction rates
iii) enantiofacial discrimination iv) ease of preparation
ii) iminium geometry control
 
To our great delight, 10 mol% of benzyl imidazolidinone salt 5•HCl was found to 
catalyze the cycloaddition of cyclopentadiene and cinnamaldehyde at room temperature (eq. 
4).  In 8 hours, the aldehyde is completely consumed and provides the cycloadduct in 93% 
ee!17  In fact, the sense of asymmetric induction observed correlates to that predicted based on 
the geometrical constraints imposed by catalyst 5 on the formation of the iminium π-system 
(Figure 1, MM3-3).  It is notable that this reaction proceeds at room temperature with high 
enantioselectivity and complete conversion in a relatively concentrated solution of methanol 
containing 5% water by volume.  The fact that this organocatalytic reaction requires no air- or 
moisture-sensitive techniques means that the crystalline, bench-stable catalyst is simply 
weighed into a capped vial to which methanol, water, aldehyde, and diene are added. 
10 mol% 5•HCl
95:5 MeOH:H2O
1.0 M, 23 °C
93% ee exo
1.3:1 exo:endo
100% conv.
8 hPh
CHO
1.0 eq3.0 eq
OPh (4)
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As the imidazolidinone structure had now proven successful as an asymmetric catalyst for 
the enantioselective Diels–Alder reaction, the efficacy of catalysts bearing other α-carbonyl 
substituents needed to be probed (Table 2).  These are synthesized in the same sequence as 
benzyl imidazolidinone catalyst 5:  the N-methyl amide of the appropriate amino acid, 
beaqring the desired R group, is condensed with acetone (as above in eq. 3).  Table 2 
compares the selectivity imparted by each amine in the Diels–Alder reaction of 
cyclopentadiene and cinnamaldehyde.  The application of catalysts derived from alanine, 
valine, tert-leucine, and phenyl glycine results in a dramatic drop in enantioselectivity (entries 
1-4, R = methyl (Me), iso-propyl(i-Pr), tert-butyl (t-Bu), and benzyl (Bn)).  The most striking 
change is that from phenyl substitution, 10/30% exo/endo ee, to benzyl substitution, 93/93% 
exo/endo ee (entries 4 and 5).  The fact that homologation of the α-amino substituent by a 
single methylene causes such a drastic improvement in enantioselectivity reinforces the 
salient features of the molecular model of the iminium formed from benzyl-substituted 
imidazolidinone 5 (MM3-3, Scheme 3 above).  Whereas the methylene link between the ring 
and the phenyl group of 5 allows the benzyl ring to swing over and shield one enantioface of 
the α,β-unsaturated iminium (6), there is almost no shielding in entry 4 as the phenyl ring can 
only rotate around the bond connecting it directly to the imidazolidinone ring.  Furthermore, 
as shown in entries 5-7 with Ar = phenyl, indole, or napthyl, the identity of the aryl ring of 
the CH2Ar moiety is not as critical for high enantioselectivity as the presence of the CH2Ar 
itself.  Adding another methylene, as in homobenzyl-substituted entry 8, also reduces the 
shielding ability of the aryl group and leads to poor enantioselectivity (46/61% exo/endo ee 
versus 90-93/88-93% exo/endo ee).  
Table 2.  Effect of α-amino substituent on selectivity of organocatalytic cycloaddition 
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20 mol%
95:5 MeOH:H2O 
1.0 M, 23 °C
1
2
3
4
5
6
7
8
Ph
CHO
1.0 eq3.0 eq
exo endo
N
N
H
R
O Me
Me
Me
OPh
•HCl
CHO
Me
exo:endoa,bentry exo ee (%) endo ee (%)R
1.5:1.0
1.4:1.0
1.0:1.3
2.2:1.0
1.3:1.0
1.2:1.0
1.3:1.0
2.0:1.0
N
H
Me
i-Pr
t-Bu
30
51
45
10
93
92
90
46
58
67
27
30
93
90
88
61
 
Preliminary Results 
As the original benzyl-substituted imidazolidinone catalyst synthesized was found to be 
the most selective and reactive, the capacity of imidazolidinone 5•HCl to enantioselectively 
catalyze the Diels-Alder reaction between a variety of α,β-unsaturated aldehydes and 
cyclopentadiene was investigated (Table 3).*  The amine-catalyzed cycloaddition tolerates a 
steric range of alkyl-substituted dienophiles (entries 1-3, R = Me, Pr, and i-Pr, 75-92% yield, 
84-86% exo ee, 90-93% endo ee).  Aromatic-substituted dienophiles provide somewhat 
higher selectivities (entries 4 and 5).  A 50-mmol cycloaddition of cyclopentadiene and 
cinnamaldehyde was carried out to demonstrate that catalyst 5•HCl (5 mol%) operates 
equally well on preparative scale (12 g (2S)-8, 99% yield, 93% exo ee). 
Table 3.  Organocatalyzed Diels–Alder reaction between cyclopentadiene and 
representative dienophiles 
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exo:endoa,b
1:1
1:1
1:1
1.3:1
1:1
entry
1
2
3
4
5
yield (%)
75
92
81
99
89
16
14
14
21
24
time (h)
OR
exo ee (%)
86 (2R)
86 (2R)
84 (2S)
93 (2S)
91 (2S)
5 mol% 5•HCl
Me
Pr
i-Pr
Ph
Furyl
endo ee (%)
90 (2R)
90 (2R)
93 (2S)
93 (2S)
93 (2S)
95:5 MeOH–H2O
23 °C
R
endoexo
R
CHO
CHO
R
 
With less-reactive cyclic and acyclic dienes, acrolein (R = H) provides excellent 
reactivity without a loss in selectivity in the imidazolidinone-catalyzed reaction (Table 4).  
Cyclohexadiene reacts efficiently to produce a bicyclic aldehyde in 14:1 endo:exo and 94% 
ee (entry 1).  Alkyl-, aryl-, and acetoxy-subsituted cyclohexene aldehydes are produced with 
high regio- and enantioselectivity (entries 2-5, 72-90% yield, 1:11-1:14 exo:endo, 83-90% 
ee).  The fact that these reactions are all performed under an aerobic atmosphere and with 
wet solvents illustrates the preparative advantages of our inexpensive, bench-stable organic 
catalyst.  In all cases, the sense of stereoinduction is consistent with iminium formation 
away from the geminal methyl groups and diene addition from the face opposite the benzyl 
group (predicted by the calculated iminium ion model MM3-3).   
Table 4.  Organocatalyzed Diels–Alder Reaction with Representative Dienes 
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diene yield producta
1:14
--
82
84
entry
1
2
    --90
1:11725
23 °CO
20 mol% 5•HCl
CHO
MeMe
R
Ph
CHO
Ph
CHO
exo:endo ee(%)a,b
H
H
H
H
94d
89
83
85
X
endo
R
Me 75     -- 90
3
4
CHO
OAcOAc
CHO
R
X
R
 
Unfortunately, attempts to expand the utility of the organocatalyzed Diels–Alder 
reaction with less reactive dienes and substituted dienophiles were unsuccessful due to 
insufficient activity of the catalyst.  For example, while cyclopentadiene is reactive enough 
to cyclize with a range of alkyl- and aryl-substituted aldehydes under these conditions, 2-
phenyl-1,3-butadiene in Table 4 was the only diene to react successfully with a dienophile 
other than acrolein.  While some substrates provide greater than 90% ee, many display 
selectivities below this standard.  In order to develop a more reactive and selective catalyst 
system, some fundamental questions needed to be answered: 
 
What parameters affect iminium formation and reactivity? 
What is the rate-determining step? 
Which catalyst features are necessary for reactivity and selectivity? 
 
A.  Studies to Determine the Mechanism of the Organocatalytic Diels–Alder  
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Faced with a fundamental need for greater reactivity to broaden scope and improve 
enantioselectivity, the effects of each reaction component required examination.  The 
understanding of the origins of the activity of imidazolidinone organocatalyst 5 garnered 
from these investigations could then be applied to provide greater substrate scope in 
conjunction with higher enantioselectivities. 
A definitive priority was to answer the question as to whether or not the reaction 
mechanism operates as postulated.  While computations support the proposed iminium 
intermediate and the trans-conformation through which it proceeds, experimental evidence 
needed to be gathered since the formation of a particular iminium is the cornerstone for not 
only reactivity but enantioselectivity.   
 
Control of Iminium Geometry is Essential for Enantiocontrol   
To reiterate, the first stereocontrol element relies on the rigidity of the iminium 
framework enforced by the geminal methyl groups at the aminal position of catalyst 5.  The 
energetic preference to avoid nonbonding interactions with the methyl substituents forces 
iminium formation over towards the benzyl group on the catalyst framework, resulting in the 
(E)-iminium isomer, as shown in Figure 2.  This overriding preference for one iminium 
isomer is the organocatalytic analogy to bidentate chelation.  The restriction of rotation 
enforced by the π-bond of the iminium ion obviates the need for a second chelating group 
such as the chiral auxiliaries often necessary in Lewis acid-catalyzed Diels-Alder reactions.  
The second stereocontrol element involves the shielding of the Re face of the dienophile by 
the benzyl group, which leaves the Si face open to undergo a cycloaddition.  It is critical to 
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note that formation of the other iminium isomer would leave the opposite prochiral face of 
the olefin exposed, leading to an erosion of enantioselectivity.   
Figure 2.  Formation of one iminium isomer is required for high enantioselectivity 
Attack occurs from Re-face
Effective Si-face coverage
 
Beginning with the first portion of the catalytic cycle, iminium formation was studied.  
Despite the multiple functional groups of these molecules, they are extremely amenable to 
observation by 1H NMR.  The geminal methyl groups on the catalyst are diagnostic and shift 
in the iminium complex, and the product aldehyde and alkene resonances are distinct from 
those of the starting diene and dienophile.   
As this model, relies on the fact that the (E)- and (Z)-iminium isomers present opposite 
enantiofaces, the high level of enantiocontrol observed is dependent on the formation of one 
iminium isomer over the other.  Therefore, the geometric structure of the iminium was 
determined experimentally by measuring nuclear effects (nOe’s) between various protons on 
the iminium ion formed from cinnamaldehyde and para-methoxy-5•HCl.  The catalyst with 
the para-methoxy group on the benzyl substituent was used to better differentiate the 
numerous phenyl peaks in the spectrum.  In addition, the electron-donating ability of the 
methoxy group stabilizes the positively charged iminium such that it is formed to a greater 
extent, making it easier to measure these through-space interactions.   
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Figure 3 shows that the nuclear interactions can be utilized to travel down the left side of 
the iminium as depicted: from the methyl group trans to the benzyl, the cis methyl group, Ha 
from the aldehyde, β-substituent Hb, and to ortho-phenyl substituent Hc.  The nOe’s 
definitively show that all of these nuclei are on the same side of the iminium ion, confirming 
that the geminal methyl groups push the iminium ion backbone towards the benzyl 
substituent and that iminium ion geometry is a key stereocontrol element.  The data also 
substantiate the calculations which depict the shielding of one enantioface of the iminium by 
the benzyl group as a second stereocontrol element.  A 1.0% nOe was measured for the 
protons on the methyl group cis to an aromatic proton meta to the methoxy group on the 
catalyst.  There was even a 0.6% nOe between the cis methyl group and one of the benzylic 
catalyst protons, a significant indication of the extent to which the benzyl group is 
positioned under the iminium ion. 
Figure 3. % nOe’s for iminium formed from cinnamaldehyde and para-methoxy-5•HCl  
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Of course, the most rigorous method of proving the (ground-state) conformation of the 
chiral iminium ion would be an x-ray crystal structure.  Formation of iminium could be 
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driven to near completion with the addition of drying agents, but attempts to recrystallize 
these foaming to crystalline solids in the moisture-free environment of a glove box did not 
yield suitable iminium crystals.  However, the solid-state structure of the HCl salt of catalyst 
5 was achieved.   
Figure 4.  X-ray crystal structure of dimethyl benzyl imidazolidinone catalyst 5•HCl 
 
 
Order in Catalyst Complex 
For the overall reaction, the order in each reaction component must be determined.  The 
reaction as designed requires reversible iminium formation followed by cycloaddition of this 
reactive intermediate (Scheme 4).  If iminium formation is the rate-determining step, the 
reaction would be first order in catalyst and dienophile but zero order in diene (x = y = 1, z = 
0) as the cycloaddition would occur after the slow step.  However, if cycloaddition is the 
rate-determining step, then the reaction would be first order in all three components (x = y = 
z = 1) as the concentration of diene would impact the reaction rate as it adds to the iminium 
formed from condensation of the catalyst with the dienophile. 
Scheme 4.  Relevant rate equations for imidazolidinone-catalyzed Diels–Alder 
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The order in the acid salt of imidazolidinone 5 was determined by gas chromatography 
(GLC) analysis of reaction aliquots of the cycloaddition between cinnamaldehyde and 
cyclopentadiene.  Tetra-n-butyl ammonium perchlorate was added to correct for any 
differences in ionic strength of the reaction medium due to the differing molar amounts of 
the perchloric acid salt of amine catalyst 5.  Benzyl methyl ether was used as the internal 
standard.  A thorough check for background reactions, non-catalyzed and catalyzed by the 
ammonium perchlorate or standard, showed that they were not significant on the timescale 
of the reaction.  The reactions were run at five times the dilution (0.2 M) of the normal 
concentration (1.0 M) for the organocatalyzed Diels-Alder reaction between 
cinnamaldehyde and cyclopentadiene for data consistency and manageable reaction times.20  
CH3CN was used as the solvent rather than MeOH, which forms acetals with the aldehyde 
products, complicating the quantification of product formation over time.  Ten aliquots were 
taken over the first 10% conversion of the reaction of (E)-cinnamaldehyde and 
cyclopentadiene for each catalyst loading.  The catalyst loading was increased in 2 mol% 
increments from 2-20 mol% 5•HClO4 (Figure 5).   
Figure 5.  Concentration of cycloadduct over time for 2-14 mol% catalyst 
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A plot of the initial rates (V0) of product formation at each of the catalyst loadings 
corresponds to a linear plot for rate of reaction versus concentration of catalyst (Figure 6).  
The R2 value is 0.99, in extremely high agreement with a linear plot of the data.  Therefore, 
the organocatalyzed Diels-Alder reaction is first order in catalyst:  doubling the 
concentration of catalyst doubles the rate of the reaction.  It also indicates that the amine and 
acid portions of the catalyst salt work in concert; the two components operate as a discrete 
entity in the reaction.  This is not surprising as the amine is the most basic species under the 
reaction conditions, generally with water as a distant second basic species, and the co-
catalyst serves to activate the aldehyde for condensation with the chiral amine catalyst.   
Figure 6.  Linear plot of Diels-Alder rates (mM/min) with 2-20 mol% 5•HClO4 
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n mol% 5•HClO4
20-n mol% (nBu4)4NClO4
95:5 CH3CN:H2O
0.2 M, 23 °C Ph
CHO
1.0 eq3.0 eq
OPh
 
 
In fact, any alteration from equimolar amounts of amine catalyst and acid co-catalyst 
causes the reaction to operate at a rate equal to the molarity of limiting catalyst component.  
For example, in the cycloaddition of cyclopentadiene and cinnamaldehyde, the initial rate of 
product formation for 10 mol% amine 5 and 8 mol% HClO4 is nearly identical to that of 8 
mol% 5•HClO4, not 10 mol% 5•HClO4 (Figure 7).  So, the fact that there is only 8 mol% 
acid means that there is only 8 mol% of the catalyst complex in solution with an additional 2 
mol% of free amine 5.  The inverse situation in which there is 10 mol% HClO4 and 8 mol% 
amine 5 again behaves more similarly to 8 mol% 5•HClO4, but as the extra 2 mol% acid can 
catalyze the racemic background reaction (whereas 2 mol% of the free amine does not), the 
alignment of initial rates is not as precise. 
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Figure 7.  Varying molar ratio of imidazolidinone catalyst to acid co-catalyst 
8 or 10 mol% 5, 8 or 10 mol% HClO4
95:5 CH3CN:H2O, 0.2 M, 23 °C
Ph
CHO
1.0 eq3.0 eq
OPh
 
 
 
Order in Dienophile and Diene 
A single study allows the determination of the order in both the α,β-unsaturated 
aldehyde and the diene.  If the reaction is first-order in each component, then the 
concentration of the dienophile and of the diene should experience exponential decay.  In 
such a case, the natural log of the ratio of the concentrations of cinnamaldehyde and 
cyclopentadiene over time should give a straight line if plotted at various catalyst loadings.  
Figure 8 plots a line with R2 = 0.99, indicating that the reaction is first order in both diene 
and dienophile.  Thus, this organocatalyzed Diels–Alder reaction is first order in catalyst, 
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dienophile, and diene, and the rate-determining step is the cycloaddition of the diene with 
the iminium formed from aldehyde and catalyst. 
Figure 8.  First order in cinnamaldehyde and cyclopentadiene  
n mol% 5•HClO4
95:5 CH3CN:H2O
0.2 M, 23 °C Ph
CHO
1.0 eq3.0 eq
OPh
 
 
Water   
As it is a product of iminium formation, and by the same token, an agent for iminium 
hydrolysis, the effect of water is not as straightforward to quantify.  Quantifying the percent 
of iminium (% iminium) is straightforward by 1H NMR as the peaks corresponding to free 
and iminium-bound catalyst are easily distinguishable.  Without water, the formation of 
iminium over time proceeds at a nearly constant rate.  At just over 4 hours, 37% iminium 
compared to 62% catalyst is observed, and this concentration holds nearly steady with 40% 
at 24 hours (Figure 9).  With the addition of 5% water by volume, the initial rate of product 
23 
 
formation is twice as fast and even faster with 10% water.  However, as the addition of 
water shifts the equilibrium position of iminium ion formation more towards iminium 
hydrolysis, the maximum % iminium observed is 28% at 60 minutes for 5% water and 24% 
at about 40 minutes for 10% water.   
Figure 9.  Percent of catalyst converted to iminium is based on amount of water added 
 
In the imidazolidinone-catalyzed cycloaddition of cyclopentadiene and cinnamaldehyde, 
there is a rate increase with the addition of 5-15% water/CH3CN, and at 20% water by 
volume, the rate begins to drop off.  Without any water added to the reaction mixture, the 
reactivity is about half of that observed with water added.  In fact, as observed by GLC 
analysis of the organocatalyzed cycloaddition of cyclopentadiene and cinnamaldehyde, 
while there is a 10% increase in rate from 5% to 10% water, the rates of 10% and 15% water 
are nearly identical (Figure 10). As for stereoselectivity with added water, the 
enantioselectivity drops only 1% moving from 5% to 10% water.  This would align with the 
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statement that at lower concentrations of water, catalyst turnover is aided while at higher 
concentrations of water, the equilibrium is pushed away from iminium formation, towards 
free catalyst and aldehyde, such that there is a smaller amount of iminium which can 
undergo cycloaddition. 
Figure 10.  Rate of Diels–Alder reaction with 5%, 10%, and 15% water added 
 
Again, the cycloaddition rate increase with the addition of water in the Diels-Alder 
reaction is mirrored with a greater initial rate of iminium formation.  However, analyzing 
iminium formation in the absence of cyclopentadiene does not give information about the 
effect of water on iminium formation under actual reaction conditions.  While observing 
solely iminium formation by 1H NMR, water increases the rate of iminium formation but 
lowers the equilibrium concentration of iminium that is reached over time.  However, under 
reaction conditions, a steady-state iminium concentration is reached in less than 10 minutes 
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as demonstrated by 1H NMR analysis of the reaction of cyclopentadiene and 
cinnamaldehyde catalyzed by 5•HClO4 in CD3CN:H2O (eq. 5).   
Interestingly, substituting D2O for H2O decreases the rate of reaction.  The Diels–Alder 
reaction between cyclopentadiene and cinnamaldehyde was carried out with either 5% H2O 
or 5% D2O in CD3CN in side-by-side round-bottom flasks.  The half-life of the 
organocatalyzed cycloaddition was determined by GLC analysis of reaction aliquots and 
increased from t1/2 = 3.8 h with 5% H2O to t1/2 = 10.4 h with 5% D2O.  Observation of the 
same reaction by 1H NMR showed the same halving of reaction of rate but also allowed the 
percent of catalyst bound as iminium to be quantified as 26-27% for water and 12-13% for 
deuterium oxide (eq. 5).  Under reaction conditions identical except for the 5% H2O or 5% 
D2O, the iminium concentration and correspondingly the rate of the reaction with H2O are 
double those of D2O.  Therefore, a proton transfer is involved in the rate determining-step, 
and the choice of acid co-catalyst should have a marked effect on the rate of product 
formation. 
5 mol% 5•HClO4
A.  95:5 CH3CN:H2O
B.  95:5 CH3CN:D2O
0.2 M, 23 °C
Ph
CHO
1.0 eq3.0 eq
OPh A.  27-26% iminium
B.  12-13% iminium
from 9 min to 49 min
(5)
 
 
B.  Identity of Acid Co-catalyst Drastically Affects Reaction Rate 
Using cyclopentadiene and cinnamaldehyde as a model system, the acid co-catalyst is 
found to be the key factor affecting the rate of the imidazolidinone-catalyzed Diels-Alder.  
Both the rate cycloaddition and extent of iminium formation are impacted. 
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More Acidic Co-catalysts Increase Rate of Product Formation 
One of the interesting features of this reaction is the striking increase in reactivity with 
increased acidity of the co-catalyst.  To quantify the magnitude of the rate differences in 
terms of reaction half-life, reactions with a range of 5•HX were conducted under standard 
conditions and monitored by GLC analysis of aliquots with benzyl methyl ether as the 
internal standard.  In both MeOH and CH3CN, the reactions repeat the observed rate 
increase going from HCl to TfOH and HClO4, which is in accordance with the pKa trend in 
organic media (entries 1-3, Table 5).  The enantioselectivity of the reactions in Table 5 
remained in the previously-obtained range of 90-94% ee, ensuring that the rate measured 
was due to the imidazolidinone-catalyzed reaction and not from the racemic background 
reaction.16  As this preliminary kinetic data highlights the acid co-catalyst as a key 
determinant of reactivity and selectivity, the exact mechanism by which the acid co-catalyst 
accelerates the reaction needed to be determined.   
Table 5.  Half-life for reactions of cyclopentadiene and cinnamaldehyde with 5•HX 
pKa (CH3CN)
1.6
2.6
10.4
entry
1
2
3
pKa (H2O)
> -10
> -10
-7
HClO4
TfOH
HCl
t1/2 (h) MeOH
3.0
3.8
4.5
t1/2 (h) CH3CN
4.2
4.6
6.9
HX
5 mol% 5•HX
95:5 MeOH–H2O
1.0 M, 23 °C endoexo
Ph
CHO
CHO
Ph
1.0 eq3.0 eq
OPh
 
There are three main components of the reaction mechanism which may be the origins of 
the acid-dependence of reaction rate: 1) iminium formation upon protonation of the enal, 2) 
cycloaddition of the diene with the unsaturated iminium, 3) hydrolysis of iminium-bound 
product to liberate catalyst (Figure 11).  It is duly noted that there are numerous minor acid-
base and addition equilibria embedded in this view of the key steps of the reaction of 
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cyclopentadiene and cinnamaldehyde, but this treatment simplifies the kinetic discussion at 
hand.  And in fact, as the concentration of iminium can be quantified by 1H NMR, the 
concentration that is measured takes into account the components of the reaction mechanism 
which contribute to iminium formation, such as the proton transfers which activate the 
aldehyde for attack by the amine catalyst and which contribute to the extrusion of water. 
Figure 11.  Iminium catalysis cycle for Diels–Alder reaction of cinnamaldehyde and 
cyclopentadiene 
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N
H
O Me
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Me
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N
O Me
Me
Me
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R
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H2O H2O
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k1k-1k3 k-3
 
 
Lack of product inhibition 
In addition, although iminium formation (k1/k-1) and the cycloaddition between iminium 
and diene (k2) are discussed, catalyst turnover (k3/k-3) is not considered (Fig. 12).  One 
reason is that the product-bound catalyst has not been observed for any Diels-Alder adduct.  
The lack of spectroscopic evidence for the product iminium is attributed to the steric 
congestion, which is related to the fact that that catalyst 5 does not function with α-
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substituted α,β-unsaturated aldehydes.  This is likely due to an unfavorable steric interaction 
in the iminium between the α-substituent and adjacent benzyl and methyl groups on the 
catalyst.  As the cycloaddition product possesses substitution at that position, hydrolysis to 
regenerate amine 5 is proposed to be extremely fast.  As product hydrolysis occurs after the 
rate determining cycloaddition step, it does not impact the reaction rate.  For the general 
reaction of cinnamaldehyde and cyclopentadiene catalyzed by 5•HX, iminium formation is 
reversible and maintains a steady state under reaction conditions (k1/k-1), and the 
cycloaddition is rate-limiting and irreversible (k2). 
Figure 12.  Components of iminium reaction mechanism affecting rate 
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Origins of the Rate Increase with Highly Acidic Co-catalysts   
For the purposes of determining the respective contributions of iminium formation and 
of cycloaddition to the co-catalyst dependent rate acceleration, the individual steps can be 
separated into their individual equations.  For the overall reaction in equation 6, the 
observed reaction rate is affected by both iminium formation (eq. 7) and attack by the diene 
on the iminium formed from condensation of the catalyst and the aldehyde (eq. 8). In other 
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words, the reaction has been shown to be first order in catalyst, dienophile, and diene 
(Chapter I-A), and as the catalyst and dienophile condense to form the reactive iminium 
intermediate, the rate of product formation should correspond to equation 6.  
k1
k-1
N
N
H•HX
O Me
Me
Me
Ph
N
N
O Me
Me
Me
Ph
Ph
X-
OPh
k1 [catalyst][aldehyde] - k-1 [iminium][H2O] = [iminium]
H2O
N
N
H•HX
O Me
Me
Me
Ph
OPh
= k [iminium] [diene]
d [product]
dt
Ph
CHO
N
N
H•HX
O Me
Me
Me
Ph
(6)
k2
N
N
O Me
Me
Me
Ph
Ph
X-
H2O
k2 [iminium][diene] = [product]
Ph
CHO
N
N
H•HX
O Me
Me
Me
Ph
(7)
(8)
 
Analysis of the origins of the rate increase with more acidic co-catalysts begins with 
iminium formation based on the individual equilibrium of which it is composed (eq. 7).  As 
rate of the reaction is directly proportional to the concentration of iminium, the extent of 
iminium formation for representative 5•HX in the absence of diene was quantified by 1H 
NMR studies of the catalyst-aldehyde iminium complex (Figure 13).  As determined by 
integration of catalyst methyl peaks compared to iminium methyl peaks, the less reactive co-
catalysts form iminium to a lesser extent but reach their equilibrium position faster.  HClO4 
forms a maximum of 73% iminium in 280 minutes, TfOH reaches 68% iminium in 220 
minutes, and HCl only yields 39% iminium in 160 minutes.  The results of these 
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experiments correlate acid co-catalysts that provide a faster reaction with a higher iminium 
concentration.   
Figure 13.  Effect of acid co-catalyst on percentage of catalyst condensed to form iminium 
over time 
 
As the inherent reactivity of each catalyst complex could also be affecting reaction rate, 
the actual cycloaddition step was studied next (eq. 8).  The reaction operates under pre-
equilibrium conditions that result in a steady state of iminium, and the cycloaddition is 
treated as irreversible and rate-determining.  From equation 3 with the concentration of 
iminium as [im] and the concentration of cyclopentadiene as [cp], the initial rate (V0) of the 
reaction can be equated as shown in equation 9.   
V0 =  k2 [im][cp] (9)  
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This equation takes into account the steps preceding the cycloaddition in the term for 
concentration of iminium.  Therefore, the rate differences for the two catalysts would be 
reflected in k2.  In other words, we needed to measure k2 (as defined by eq 3) for the rate-
determining cycloaddition as shown in equation 10 to compare acid co-catalysts HClO4, 
TfOH, and HCl. 
k2 =
V0
[im][cp]
(10)
 
Fortunately, each of these variables is easily quantified by 1H NMR under reaction 
conditions.  To simplify the treatment of the kinetics further, the reaction was carried out 
with 10 equivalents of cyclopentadiene such that its concentration was considered constant 
over the first 10% conversion.  With the reaction running pseudo-zero order in 
cyclopentadiene, the concentration of iminium and products formed were measured over the 
initial course of the reaction.19  Comparing the values of k2 under equivalent conditions apart 
from the identity of the acid co-catalyst, the rate constant for the cycloaddition with HClO4 
= 0.0775, TfOH = 0.0752, HCl = 0.0727, and TFA = 0.0560 (mmol·min)-1. (27-21%im)  
Therefore, more acidic co-catalysts provide a faster rate and greater reaction scope by 
forming greater quantities of a more reactive iminium.  Again, only one iminium 
conformation is observed throughout these experiments in complete agreement with the 
structural results of molecular modeling studies.  
 
C.  Improved Enantioselectivity and Expanded Substrate Scope Using More Acidic Co-
catalysts in the Imidazolidinone-Catalyzed Diels–Alder Reaction 
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The catalyst systems discovered from these investigations provide greater substrate 
scope in conjunction with higher enantioselectivities in the organocatalyzed Diels–Alder.   
 
Increase in Reactivity Translates to Higher Enantioselectivities 
In determining whether the greater reactivity imparted by more acidic co-catalysts is 
delivered in conjunction with higher enantioselectivity for the entire range of substrates, the 
organocatalytic addition of cyclopentadiene to hexenal was reexamined first.  Table 6 
demonstrates that the more acidic HClO4 and TfOH acid co-catalysts raise enantioselectivity 
and slightly augment diastereoselectivity in the formation of the cycloadduct compared to 
HCl.  Less acidic co-catalysts such as TFA provide even poorer reactivity and lower 
enantiomeric ratios.  Therefore, the ability of the acid co-catalyst to increase reactivity also 
confers increased enantioselectivity of amine-catalyzed reactions. 
Table 6.  Co-catalyst effects on the cycloaddition of (E)-hex-2-enal and cyclopentadiene 
endo:exo
1.3:1
1.1:1
1.0:1
entry
1
2
3
OPr
exo ee (%)
88  
87 
86
5 mol% 5•HX
95:5 MeOH:H2O
23 °C
HClO4
TfOH
HCl
endo ee (%)
93 
94
90
HX
endoexo
Pr
CHO
CHO
Pr
 
Increased Range of Dienes and Dienophiles 
The superior activity of HClO4- and TfOH-derived amine salts marked these catalysts 
for further study.  Table 7 shows that the Diels-Alder reaction of a range of dienophiles with 
cyclopentadiene was improved to 90-93% exo ee and 94-96% endo ee (entries 1-6, from 84-
93% exo ee and 90-93% endo ee with HCl).  Interestingly, aromatic α,β-unsaturated 
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aldehydes were not as improved by the more acidic co-catalysts as the aliphatic α,β-
unsaturated aldehydes were (entry 4, R = Ph from 91% exo ee, 93% endo ee; entry 5, R = 
furyl from 93% exo ee, 93% endo ee).  The similar ee’s with HClO4, TfOH, and HCl may be 
due to the lesser tendency of a more conjugated phenyl- or furyl-substituted α,β-unsaturated 
aldehyde to participate in a racemic background reaction to begin with.  The available 
functionality in the Diels-Alder reaction with cyclopentadiene was expanded with (2E)-4-
oxobut-2-enyl benzoate (entry 6).  This benzoyloxy-substituted crotonaldehyde is less prone 
to decomposition and produces a bicycle with similar selectivities as those observed with 
crotonaldehyde (95/91% ee versus 95/92% ee for crotonaldehyde, entry 1) but with a 
protected-oxygen substituent.  
Table 7.  Diels-Alder of alkyl- and aromatic-substituted aldehydes and cyclopentadiene 
endo:exoa,b
1.2:1
1.1:1
1.0:1
1.1:1
1:1.3
1:1.3
entry
1
2
3
4
5
6
yield (%)
83
73
90
92
93
89
16
25
23
28
18
11
time (h) exo ee (%)
92 
91 
90
92 
93 
91
5 mol% 5•HClO4
Me
Pr
i-Pr
Ph
Furyl
CH2OBz
c
endo ee (%)
95 
94 
96 
94 
94
95
95:5 MeOH–H2O
4
4
4
23
23
4
temp (°C)
OR
R
endoexo
R
CHO
CHO
R
 
While cyclopentadiene exhibits broad dienophile scope, attempts to use dieneophiles 
other than acrolein with less reactive dienes were generally not successful.  In fact, the 
observed increase in reaction time between cyclopentadiene and hexenal as opposed to 
crotonaldehyde suggests that sterics play a role in governing the feasibility of these reactions 
(Table 7, entries 1-3).  Unfortunately, the benzoyloxy aldehyde which performed so well 
with cyclopentadiene (Table 7, entry 6) is not sufficiently more reactive than crotonaldehyde 
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to react well with cyclohexadiene.  As an ester group at the β-position is sterically smaller 
than a methyl group, and the electron-withdrawing effect of the ester group should result in 
a more reactive iminium ion, it was proposed that an ester-substituted aldehyde would 
provide the desired reactivity.  Indeed, the reaction of cyclohexadiene with (E)-methyl-4-
oxobutenoate proceeded similarly to the reaction with acrolein and provided β-ester 
aldehyde 9 in 97% ee, 5:1 endo:exo, and 92% yield (Table 8, entries 1 and 2).  These 
examples demonstrate that the low diastereoselectivity is a function of cyclopentadiene itself 
and not the catalyst system 
Table 8.  Organocatalyzed Diels-Alder with cyclohexadiene 
yield (%)entry
O
20 mol% 5•HX
CHOR
endo:exo ee (%)a,b
R
16:1
5:1
93
92
24
23
time (h)
(2S)-endo
–10
4
temp (°C)
96
97
H
CO2Me
1
2
HClO4
TfOH
HX
95:5 CH3CN–H2O
R
 
Acyclic, methyl-substituted dienes were examined next.  These aliphatic dienes continue 
to exhibit better enantioselectivity and conversion with HClO4 and TFOH as co-catalysts 
than with HCl as a co-catalyst at these lower temperatures.  For example, the Diels-Alder 
reaction between isoprene and acrolein does not proceed to complete conversion at –10 ºC 
with HCl.  However, HClO4 as the co-catalyst provides a 92% ee and 94% yield (Table 9, 
entry 1).  The effect of additional substitution on the diene was examined with 2,3-
dimethylbutadiene which exhibits similar reactivity to isoprene, producing tetrasubstituted 
cyclohexenes in 91% ee, 92% yield (entry 3).  2-Methyl-1,3-pentadiene exhibited similar 
reactivity to other alkyl-substituted dienes with acrolein (88% ee,  84% yield, entry 5).  The 
high enantioselectivity for and excellent conversion to β-ester aldehyde cycloadducts was 
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extremely encouraging, demonstrating that the butenoate aldehyde reacts with as great a 
variety of dienes as acrolein.  Furthermore, the butenoate aldehyde allows for an expanded 
number of substrates that possess an additional functional handle with defined 
stereochemistry.   
Table 9.  Methyl-substituted dienes with acrolein or butenoate aldehyde 
yield (%)entry
O
20 mol% 5•HClO4
R
ee (%)a,b
94
81
92
88
84c
11
23
15
23
26
time (h)
–10
–10
–20
–20
–20
temp (°C)
92
95
91
95
88
H
CO2Me
H
CO2Me
H
1
2
3
4
5
Me
CHO
Me
R
diene
2-methylbutadiene
2-methylbutadiene
2,3-dimethylbutadiene
2,3-dimethylbutadiene
2-methyl-1,3-pentadiene
R
 
Aldehydes bearing a styrenyl moiety are accessed by a Diels-Alder reaction between 2-
phenyl-1,3-butadiene and a variety of α,β-unsaturated aldehydes (Table 10).  Acrolein 
proves problematic due to its propensity to polymerize.  Conditions were found that 
emulated previous results for the reaction of acrolein and 2-phenyl-1,3-butadiene (entry 1, 
83% ee, 87% yield).17  2-Phenyl-1,3-butadiene was the only diene with the exception of 
cyclopentadiene which had been shown in our original communication react cleanly with 
(E)-crotonaldehyde.17  Due to the high propensity of crotonaldehyde to polymerize, the 
equivalencies of diene to aldehyde were varied, demonstrating that excess aldehyde provides 
better conversion than excess diene in this case.  Careful GLC monitoring of the reaction of 
1 equivalent of 2-phenylbutadiene to 3 equivalents of crotonaldehyde and 5•TfOH 
demonstrates that conversion reached a maximum then decreased after 18 hours, an 
indication of product decomposition.  This cycloaddition to form a β-methyl aldehyde 
reaches 91% ee and 70% yield in 16 hours (entry 2).  In entry 3, the butenoate aldehyde 
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reacts to provide a β-ester aldehyde cycloadduct in 90% ee and 86% yield.  As the reaction 
of 2-phenylbutadiene proceeds smoothly with crotonaldehyde, it seems reasonable that this 
diene would cyclize efficiently with the benzoyloxy aldehyde as these aldehydes exhibit 
similar reactivity.  The benzoyloxy aldehyde continues to be more reactive than 
crotonaldehyde at 4 °C, delivering 91% ee in 86% yield in 13 hours (as compared to 90% ee 
in 16 hours for crotonaldehyde, entry 4 versus 2).   
Table 10.  2-Phenyl-1,3-butadiene with substituted α,β-unsaturated aldehydes 
Ph
yield (%)entry
O
20 mol% 5•HX
R
87
70
87
86
7
16
24
13
time (h)
–10
4
–20
4
temp (°C)
83
91
90
90
H
Me
CO2Me
CH2OBz
1
2
3
4
CHO
RPh
TfOH
HClO4
HClO4
TfOH
95:5 CH3CN–H2O
R R ee (%)b,c
 
1-Acetoxybutadiene represents the first heteroatom-substituted diene in this study.  
Initial studies have shown that the reaction with acrolein provides the desired cycloadduct in 
85% ee in room temperature trifluoroethanol.17  Lowering the temperature and changing the 
solvent to CH3CN yielded an significant increase to 96% ee and a higher endo:exo ratio (eq. 
11). 
OAc
O
20 mol% 5•HClO4
95:5 CH3CN:H2O, –10 °C
96% ee
19:1 endo:exo
83% conv.
24 h
CHO
OAc
(11)
 
Having extended the functional handles available on the dienophile, the utility of dienes 
with additional functionality was examined next.  For example, if the oxygen in 1-acetoxy 
butadiene is replaced with nitrogen, this organocatalytic Diels-Alder reaction can potentially 
deliver enantiopure β-amino acid precursors, which are valuable architectures in asymmetric 
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synthesis.  Surprisingly, 1-carbamate-substituted dienes of the Oppolzer-Overman type have 
been known for decades, and yet, they have only recently been utilized in enantioselective 
Diels-Alder reactions.  In fact, the first example of an enantioselective Lewis acid-catalyzed 
Diels-Alder reaction of a simple amine-substituted diene was by Evans et al. in 1999.4d 
Solvent studies showed that the imidazolidinone-catalyzed reaction of N-Cbz-amino-1,3-
butadiene with acrolein is far less solvent dependent than previous cycloaddition partners.  
CH3CN, acetone, isopropanol, dioxane, diethyl ether, and tetrahydrofuran (THF) exhibit 90-
93% ee at 4 ºC.  Lowering the temperature to –20 ºC, the reaction proceeded in 95% ee and 
86% yield in THF (Table 12, entry 1).  For crotonaldehyde and N-Cbz-amino-1,3-butadiene, 
5•HClO4 provides 97% ee and 4:1 endo:exo (entry 2).  Once again, the methyl ester-
substituted α,β-unsaturated aldehyde exhibits similar reactivity to acrolein at –20 ºC.   
However, whereas acrolein is highly enantioselective in CH3CN, the butenoate aldehyde is 
poorly selective in CH3CN (43% ee, 60% conv., 17h).  However, substituting THF for 
CH3CN provides 93% ee and 79% yield with only the endo isomer visible by 1H NMR (entry 
3).  Note that this imidazolidinone-catalyzed Diels-Alder reaction creates a single, 
enantioenriched isomer of a β-amino acid precursor, which possesses three functionally-
differentiated heteroatomic handles (carbamate, aldehyde, and butenoate) on a cyclohexene 
ring (entry 3).  Finally, the benzoyloxy-substituted α,β-unsaturated aldehyde affords the 
highest enantioselectivity seen in the organocatalyzed Diels-Alder reaction, 99% ee in 83% 
yield with 10:1 diastereoselectivity at –20 ºC (entry 4). 
Table 11.  Cycloadducts of N-Cbz-amino-1,3-butadiene  
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NHCbz
CHO
NHCbz
yield (%)entry
O
20 mol% 5•HX
R
ee (%)
86
71
79
83
6
9
14
17
time (h)
–20
–10
–20
–10
temp (°C)
95
97a
93
99
H
Me
CO2Me
CH2OBz
1
2
3
4
TfOH
HClO4
TfOH
HClO4
95:5 THF:H2O
endo:exo
6:1
4:1
>20:1
10:1
HXR
 
The excellent reactivity of N-Cbz-diene with acrolein (95% ee in 6 h at –20 ºC) 
prompted a catalyst loading study (Table 12).  Entry 4 shows that the catalyst loading can be 
decreased to 2% (below even the 5% loading for cyclopentadiene reactions) while 
maintaining a 90% ee.  This is an especially reactive diene, and the fact that there is a 
decrease in enantioselectivity with lower catalyst loadings is probably due to the background 
reaction, which can now compete at longer reaction times. 
Table 12.  Catalyst loading study for amino diene and acrolein 
NHCbz
yield (%)mol% 5•TfOHentry
O
n mol% 5•TfOH
95:5 THF:H2O, –20 °C
ee (%)
86
84
82
79
6
11
25
52
time (h)
95
93
91
90
20
10
5
2
1
2
3
4
endo:exo
6:1
6:1
6:1
6:1
NHCbz
CHO
 
These studies have demonstrated that a key component to the successful optimization of 
organocatalytic cycloadditions has been the use of perchloric and triflic acid derived amine 
catalysts.  The general strategy of taking advantage of the increased reaction rates with more 
acidic co-catalysts to lower reaction temperature, and thereby providing higher 
enantioselectivities, was applied to a range of new substrates.  The number of chiral building 
blocks available through an imidazolidinone-catalyzed Diels-Alder reaction was doubled by 
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expanding the types and number of substituents both on the dienes and the α,β-unsaturated 
aldehyde dienophiles.  Additional Diels-Alder adducts were synthesized in 90-99% ee, and 
except for one, none of these products had been previously synthesized asymmetrically.  
These adducts display a range of substitution on the product alkene and adjacent to the 
aldehyde, including alkyls, aryls, esters, amines, and an acetate.  These multiple functional 
handles make the products of the imidazolidinone-catalyzed Diels-Alder extremely useful 
chiral building blocks. 
 
D.  Origins of the Effect of Catalyst Structure on Reactivity and Enantioselectivity 
Whereas the use of more acidic co-catalysts vastly improved the reactivity, selectivity, 
and scope of the imidazolidinone-catalyzed Diels–Alder reaction, it became clear that 
modifications to the catalyst architecure would be necessary to improve other methodologies 
under development in the MacMillan group.  The key is to modify the catalyst structure 
without losing the iminium geometry control exhibited by the first-generation dimethyl 
imidazolidinone catalyst.  Only one iminium isomer is observed in the 1H NMR studies with 
catalyst 5 because the steric bulk of the geminal methyl groups forces the iminium geometry 
towards the benzyl substituent.  However, the methyl group trans to the benzyl projects up 
and partially blocks the hemisphere from which the nucleophile attacks according to our 
model.  It was postulated that removal of this methyl group would allow for greater 
reactivity.  The effect of the each individual methyl groups was probed by synthesizing 
trans- and cis-monomethyl imidazolidinone catalysts (eq. 12).  The N-methyl amide of 
phenylalanine is now condensed with acetaldehyde (rather than acetone as with catalyst 5).  
The reaction is conducted with the slightly acidic hydroscopic molecular sieves rather than 
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adding any other acid source, and it produces a 1:1 ratio of diastereomeric monomethyl 
catalysts separable by preparatory HPLC. 
N
H
O
NH2
Me
pulverized 3A mol sieves
MeOH
Ph
1:1 ratio of trans- to cis-catalysts
O
MeH
N
N
H
O Me
Me
Ph
N
N
H
O Me
Me
Ph
(12)
7 8
  
The reactivity and selectivity of these catalysts was assessed through the Diels–Alder 
reaction between cinnamaldehyde and cyclopentadiene monitored by GLC (Scheme 5, 
catalysts 7 and 8).  Trans-catalyst 7 exhibits poor enantioselection and a 50% slower rate 
than 5.  As expected, the cis-catalyst (8) is nearly twice as reactive as the dimethyl benzyl 
imidazolidinone (5) and provides increased exo selectivity but extremely low 
enantioselectivity.  1H NMR observation of iminium formation between cinnamaldehyde (1 
eq.) and trans-3-methyl imidazolidinone·HCl (7•HCl, 1 eq.) displays a 3:1 ratio of iminium 
geometries.  In short, although removing the trans methyl substituent does nearly double the 
rate of reaction, the monomethyl catalysts do not possess the steric bulk necessary for the 
control of iminium ion geometry required for high levels of enantioselectivity.  The simple 
solution is to create a cis-imidazolidinone catalyst with a sterically demanding group at the 
aminal position.  
Scheme 5.  Effects of 3-methyl substitution on catalyst reactivity and selectivity 
OPh
Ph
CHO
t1/2 = 6.3 h
1.4:1 endo:exo
59% exo ee, 80% endo ee
1)  5 mol% catalyst•HCl
     95:5 MeOH:H2O, 23 °C
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Cis-3-tert-butyl-5-benzyl imidazolidinone (9) exhibits high reactivity, catalyzing 
reactions that are not efficient with 5.20  Furthermore, the high enantioselectivities afforded 
by this second-generation catalyst dictate that a single tert-butyl group is of adequate size to 
control iminium geometry; the singularity of iminium ion geometry was confirmed when 
reactions were monitored by 1H NMR.  In comparing the extent of iminium formation for 
catalysts 5 and 9, it was expected that more reactive catalyst 9 would produce a higher 
equilibrium concentration of the reactive iminium intermediate (as with more acidic co-
catalysts).  Surprisingly, the concentration of iminium 10 was half that of 6 (Scheme 6). 
Scheme 6.  Percent of catalyst forming reactive iminium ion 
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 If the extent of iminium formation (k1/k–1) is not the origin of the greater reactivity of 
catalyst 9, then it must be the inherent reactivity of the corresponding iminium intermediate 
10 (k2).  Again setting k2 equal to V0/([im][cp]) for each catalyst, the concentration of 
iminium ion and cycloadduct formed were measured over the initial 10% of the reaction by 
1H NMR.  Conducting the organocatalytic cycloaddition with a large, near constant [cp], the 
concentration of iminium was steady over the first half of the reaction, 44% for first-
generation catalyst 5 and 32% for second-generation catalyst 9.  The rate constant for the 
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cycloaddition with cis-t-butyl catalyst 9 is twice that of dimethyl catalyst 5 (Scheme 7).  
Therefore, the second-generation catalyst provides a faster rate and greater reaction scope 
by forming a much more reactive iminium ion, albeit at a lower concentration than the 
iminium formed from the first-generation catalyst.  
Scheme 7.  Comparison of reactivity of 1st- and 2nd-generation catalyst iminium ions 
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The imidazolidinone-catalyzed Diels–Alder reaction developed in the MacMillan 
Grouop activates enal substrates via a reversible condensation to form a chiral α,β-
unsaturated iminium ion upon which the rate-determining cycloaddition occurs.  Kinetic 
studies highlight the importance of the acid co-catalyst and identified a more reactive 
catalyst complex, significantly improving enantioselectivities and vastly expanding the 
substrate scope of the first highly enantioselective organocatalytic Diels–Alder reaction.  
Exploration of the crucial components of catalyst architecture led to the development of a 
second-generation tert-butyl imidazolidinone scaffold that not only catalyzes 
cycloadditions, but conjugate additions, hydrogenations, and tandem reactions of aldehydes 
with excellent selectivity.  
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Supporting Information 
 
General Information.  All solvents were used as obtained from commercial suppliers 
unless otherwise indicated.  Other commercial reagents were purified prior to use following 
the guidelines of Perrin and Armarego.1 Thin layer chromatograms (TLC) was performed on 
EM reagents 0.25 mm silica gel 60-F plates.  Visualization of the developed chromatogram 
was performed by fluorescence quenching, KMnO4 stain, or para-anisaldehyde stain.  
Organic solutions were concentrated under reduced pressure on a Büchi rotary evaporator.  
ChromatograPHic purification of products was accomplished using forced-flow 
chromatograms on ICN 60 32-64 mesh silica gel 63 according to the method of Still.2  
1H and 13C NMR spectra were recorded on a Varian Mercury 300 (300 MHz and 75 MHz, 
respectively) instrument, as noted, and are internally referenced to residual protio solvent 
signals.  Data for 1H NMR are reported as chemical shift (δ ppm), multiplicity (s = singlet, d 
= doublet, t = triplet, q = quartet, m = multiplet), coupling constant (Hz), integration, and 
assignment.  Data for 13C NMR are reported as chemical shift.  IR spectra were recorded on 
Perkin-Elmer Paragon 1000 spectrometer as thin films and reported in terms of frequency of 
absporption.  Mass spectra were obtained from the California Institute of Technology 
facility.  GLC was performed on Hewlett-Packard 6850 and 6890 Series gas chromatographs 
equipped with a split-mode capillary injection system and flame ionization detectors using 
the following columns:  Bodman Chiraldex β-DM (30 m × 0.25 mm), Bodman Chiraldex Γ-
TA (30 m × 0.25 mm), and C&C Column Technologies CC-1701 (30 m × 0.25 mm). High 
                                                
1 Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; Fourth ed.; Butterworth-
Heinemann:  Oxford, 1996. 
2Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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performance liquid chromatograms (HPLC) analysis was performed on a Hewlett-Packard 
1100 Series HPLC, UV detection monitored at 254 nm, using a Chiralcel OD-H column (1.6 
× 25 cm) and Chiralcel OD guard (1.6 × 5 cm).  
Progress of the Diels–Alder reaction was typically monitored by TLC analysis or by 
GLC analysis of reaction aliquots. 
 
General Procedure for Amine-Catalyzed Diels–Alder Reaction:  To a 1-dram 
vial equipped with a magnetic stir bar and charged with an acid salt of (2S, 5S)-5-benzyl-
2,2,3-trimethylimidazolidin-4-one was added solvent/H2O (95:5 v/v), and an α,β-unsaturated 
aldehyde. After stirring for 5 minutes in the appropriate temperature bath, the diene was 
added in one portion, and the resulting solution was stirred at constant temperature. Upon 
consumption of the limiting reagent (determined by TLC or by GLC conversion assay on 
parallel reaction with benzyl methyl ether as standard), the reaction mixture was then 
directly purified by silica gel chromatograms and fractions concentrated in vacuo (with ice 
bath for volatile substrates) to provide the title compounds.   
 
General Procedure for Amine-Catalyzed Diels–Alder Reaction in MeOH:  To a 
1-dram vial equipped with a magnetic stir bar and charged with an acid salt of (2S, 5S)-5-
benzyl-2,2,3-trimethylimidazolidin-4-one in CH3OH/H2O (95/5 v/v, 1.0 M) was added the 
α,β-unsaturated aldehyde. After stirring for 5 minutes in the appropriate temperature bath, 
the diene was added in one portion, and the resulting solution was stirred at constant 
temperature. Upon consumption of the limiting reagent (determined by TLC or by GLC 
conversion assay on parallel reaction with benzyl methyl ether as standard), the reaction 
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mixture was diluted with Et2O and washed successively with H2O and brine.  The organic 
layer was dried (Na2SO4), filtered, and concentrated.  Hydrolysis of the product dimethyl 
acetal was performed by stirring the crude product mixture in TFA:H2O:CH2Cl2 (1:1:3) for 2 
h at room temperature, followed by neutralization with sat. aq. NaHCO3 and extraction with 
Et2O.  Purification of the Diels–Alder adduct was accomplished by silica gel (solvents 
noted) and fractions concentrated in vacuo to provide the title compounds.   
Enantioselectivity was determined by chiral GLC or HPLC analysis of the title 
compound or its derivative.  Absolute configurations were determined by comparison to 
literature optical rotation values where indicated.  Other absolute configurations were 
assigned by chemical correlation.  
 
 
(1S, 2R, 3S, 4R)-3-Propyl-bicyclo[2.2.1]hept-5-ene-2-carboxaldehyde and (1R, 
2R, 3S, 4S)-3-Propyl-bicyclo[2.2.1]hept-5-ene-2-carboxaldehyde.  Prepared according to 
the general procedure with (E)-hex-2-enal (142 µL, 1.22 mmol), cyclopentadiene (302 µL, 
3.66 mmol), and 7 (16 mg, 0.061 mmol) to provide the title compound as a colorless oil in 
91% yield (184 mg, 1.12 mmol) after silica gel chromatograms (10% EtOAc/hex); 1.1:1.0  
endo:exo; endo 94% ee; exo 91% ee.  Product ratios were determined by GLC (Bodman Γ-
TA column, 102 °C isotherm, 23 psi); exo isomers tr = 20.1 min and 21.1 min, endo isomers 
tr = 20.7 min and 22.5 min.  1H NMR for the endo isomer was consistent with previously 
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reported values.3  1H NMR for the exo isomer was consistent with previously reported 
values.4 
 
(1S, 2R, 3S, 4R)-3-Methylbicyclo[2.2.1]hex-5-ene-2-carboxaldehyde and (1R, 2R, 
3S, 4S)-3-Methylbicyclo[2.2.1]hex-5-ene-2-carboxaldehyde. Prepared according to the 
general procedure with (E)-crotonaldehyde (871 µL, 10.0 mmol), cyclopentadiene (2.50 mL, 
30.0 mmol), and 7 (109 mg, 0.50 mmol) to afford the title compound as a colorless oil in 
83% yield (1.02 g, 7.5 mmol) after silica gel chromatograms (3% EtOAc/hex); 1.2/1.0 
endo:exo, endo 95% ee, exo 92% ee.  Product ratios were determined by GLC (Bodman β-
DM column, 60 oC, 40 min; 5 oC/min gradient, 23 psi); (1S, 2R, 3S, 4R) endo isomer tr =  
41.5 min, (1R, 2S, 3R, 4S) endo isomer tr = 45.1 min, 42.4 min; endo isomers tr = 38.6 min 
and 42.4 min.  1H NMR data for the endo isomer is consistent with previously reported 
values.5  1H NMR data for the exo isomer is consistent with previously reported values.4 
 
(1S, 2S, 3S, 4R)-3-Isopropyl-bicyclo[2.2.1]hept-5-ene-2-carboxaldehyde and (1R, 
2S, 3S, 4S)-3-Isopropyl-bicyclo[2.2.1]hept-5-ene-2-carboxaldehyde.  Prepared according 
to the general procedure with (E)-4-methyl-pent-2-enal (142 µL, 1.22 mmol), 
cyclopentadiene (302 µL, 3.66 mmol), and 7 (16 mg, 0.061 mmol) to afford the title 
compound as a colorless oil in 92% yield (162 mg, 0.99 mmol) after silica gel 
chromatograms (10% EtOAc/hex); 1.0:1.0  endo:exo; endo 96% ee; exo 90% ee.  Product 
ratios were determined by GLC (Bodman β-DM column, 85 °C isotherm, 1 ml/min); endo 
                                                
3 Sartor, D.; Saffrich, J.; Helmchen, G. Synlett 1990, 197. 
 
4 Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 4243. 
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isomers tr = 43.5 min and 44.4 min, exo isomers tr = 42.1 min and 46.2 min.  1H NMR data 
for the endo and exo isomer are consistent with previously reported values.4 
 
(1S, 2S, 3S, 4R)-3-Furan-2-yl-bicyclo[2.2.1]hept-5-ene-2-carboxaldehyde and 
(1R, 2S, 3S, 4S)-3-Furan-2-yl-bicyclo[2.2.1]hept-5-ene-2-carboxaldehyde.  Prepared 
according to the general procedure with (E)-3-furyl-acrolein (166 mg, 1.36 mmol), 
cyclopentadiene (329 µL, 3.99 mmol) and 1·HClO4 (34 mg, 0.13 mmol) to afford the title 
compound as a colorless oil as a mixture of acetal and aldehyde in 89% yield (5.7:1, 270 
mg) after silica gel chromatography (10% EtOAc/hex); 1.1:1.0  endo:exo; endo 94% ee; exo 
92% ee.  Product ratios were determined by GLC (Bodman β-DM column, 140 °C isotherm, 
1 ml/min); exo isomers tr = 11.2 min and 12.0 min, endo isomers tr = 11.6 min and 12.3 min.  
1H NMR data are consistent with previously reported values.4 
 
 
(1S, 2S, 3S, 4R)-3-PHenylbicyclo[2.2.1]hex-5-ene-2-carboxaldehyde and (1R, 2S, 
3S, 4S)-3-PHenylbicyclo[2.2.1]hex-5-ene-2-carboxaldehyde.   Prepared according to the 
general MeOH procedure with (E)-cinnamaldehyde (6.36 mL, 50.4 mmol), cyclopentadiene 
(12.5 mL, 151 mmol), and 1·TfOH (640 mg, 2.5 mmol) to afford the title compound as a 
colorless oil in 93% yield (12.2 g, 50.0 mmol) after silica gel chromatography (10% 
EtOAc/hex); 1.0/1.3 endo:exo, endo 94% ee, exo 93% ee.  Product ratios were determined 
by GLC (Bodman Β-DM column, 140 oC isotherm, 23 psi); endo isomers tr = 31.2 min and 
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33.5 min, exo isomers tr = 29.7 min and 32.5 min.  1H NMR data are consistent with 
previously reported values.5 
 
(1R, 2S)-2,4-Dimethyl-cyclohex-3-ene-1-carboxaldehyde.  To a –20 °C solution of 
1·HClO4 (27 mg, 0.11 mmol) in THF/H2O (95/5 v/v, 1.0 M) was added acrolein (102 µL, 
1.53 mmol), and 2-methyl-1,3-pentadiene (60 µL, 0.51 mmol).  The solution was stirred for 
26 h then directly purified by silica gel chromatography (10% EtOAc/hex) affording the 7 as 
a colorless oil in 84% yield (85 mg, 12 mmol); 10:1 endo:exo; 88% ee.  Product ratios were 
determined by GLC (Bodman β-DM column, 90 °C initial temp, 30 psi); endo isomers tr = 
9.4 min and 10.0 min, exo isomers tr = 5.4 min and 7.2 min. 1H NMR data are consistent 
with previously published spectra.5  
 
(1R)-4-methyl-3-cyclohexene-1-carboxaldehyde. To a –10 oC solution of 1·HClO4 
(32 mg, 0.12 mmol) in CH3NO2/H2O (95/5 v/v, 1.0 M) was added acrolein (1.0 mL, 15 
mmol), and isoprene (0.50 mL, 5 mmol). The solution was stirred at -10 oC for 11 hr, then 
directly placed onto a silica gel column and eluted with 3% Et2O/pentane, affording the title 
compound as a colorless oil in 94% yield (745 mg, 92% ee).  Product ratios were determined 
by GLC (Bodman Γ-TA column, 30 oC isotherm 40 min, 0.5 oC/min gradient, 30 psi) tr =  
74.6 min, 75.8 min.  1H NMR data are consistent with previously reported values. 5 
 
(1R, 2S)-Acetic acid 6-formyl-cyclohex-2-enyl ester.  To a solution of 1·HClO4 (27 
mg, 0.11 mmol) and benzylmethyl ether (50 mg, 0.36 mmol) in CH3CN/H2O (95/5 v/v, 1.0 
                                                
5 Ishihara, K.; Kurihara, H.; Matsumoto, M; Yamamoto, H.  J. Am. Chem. Soc., 1998, 120, 6920. 
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M) was added acrolein (214 µL, 3.21 mmol) followed by 1-acetoxybutadiene (127 µL, 1.07 
mmol).  The resulting solution was stirred until the diene was consumed (GLC analysis, CC-
1701 column, 50 °C isotherm for 10 min, then 40 °C/min to 280 °C isotherm, 23 psi); cis-1-
acetoxybutadiene tr = 10.3 min, trans-1-acetoxybutadiene tr = 9.9 min, benzylmethyl ether tr 
= 13.5 min, trans-acetic acid 6-formyl-cyclohex-2-enyl ester tr = 14.2 min, cis-acetic acid 6-
formyl-cyclohex-2-enyl ester tr = 16.4 min.  A GLC yield of 83% was determined by 
comparison of the peak areas of acetic acid 6-formyl-cyclohex-2-enyl ester and 
benzylmethyl ether; 96% ee, 19:1 endo:exo. Enantiomeric excess was determined by GLC 
analysis using a Bodman Γ-TA column (90 °C isotherm 78 min, ramp 3 ºC/min to 108 ºC, 
23 psi) tr = 47.7 min and 80.0 min.  1H NMR data are consistent with previously reported 
values.6   
 
(2R)-Bicyclo[2.2.2]oct-5-ene-2-carboxaldehyde.  To a –10 ºC solution of 1·HClO4 
(32 mg, 0.12 mmol) in CH3CN/H2O (95/5 v/v, 1.0 M) was added acrolein (501 µL, 7.5 
mmol), and cyclohexadiene (238 µL, 2.5 mmol).  The solution was stirred for 24 h, after 
which time the reaction mixture was applied directly to a silica gel column and eluted with 
(5% ether/pentane) to afford the title compound as a colorless oil in 93% yield (280 mg, 
2.06 mmol); 16:1 endo:exo; 96% ee.  Product ratios were determined by GLC (Bodman β-
DM column, 120 °C isotherm, 1 ml/min) tr = 31.9 min and 34.8 min.  1H NMR data were 
consistent with previously reported values.5 
 
                                                
6 Gouesnard, J.P.; Martin, G.J. Tetrahedron 1974, 30, 151. 
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 (1R)-4-Phenyl-3-cyclohexene-1-carbaldehyde.  To a –10 °C solution of 2-phenyl-
1,3-butadiene7 (89 mg, 0.68 mmol) in CH3CN/H2O (95/5 v/v, 1.0 M) was added 1·TfOH 
(29.8 mg, 0.14 mmol) and acrolein (135 µL, 2.1 mmol).  The solution was stirred at -10 oC 
for 7 hr, then directly placed onto a silica gel column and eluted with 5% EtOAc/hex 
affording the title compound as a colorless oil in 87% yield (114 mg, 0.61 mmol, 83% ee).  
Product ratios were determined by GLC (Bodman β-DM column, 120 °C isotherm, 23 psi) tr 
= 86.8 min and 87.8 min.  1H NMR data are consistent with previously reported values.4 
 
(1R, 6S)-6-Methyl-4-phenylcyclohex-3-ene-1-carbaldehyde.  To a 4 °C solution of 
2-phenyl-1,3-butadiene7 (89 mg, 0.68 mmol) in CH3CN/H2O (95/5 v/v, 1.0 M) was added 
1·HClO4 (29.8 mg, 0.14 mmol) and (E)-crotonaldehyde (135 µL, 2.1 mmol).  The solution 
was stirred at +4 oC for 16 hr, then directly placed onto a silica gel column and eluted with 
5% EtOAc/hex affording the title compound as a colorless oil in 70% yield (114 mg, 0.61 
mmol, 91% ee).  Product ratios were determined by GLC (Bodman β-DM column, 165 °C 
isotherm, 23 psi) tr = 46.9 min and 49.4 min.    1H NMR data are consistent with previously 
reported values.4 
 
(1R)-3,4-dimethylcyclohex-3-ene-1-carbaldehyde. To a –10 oC solution of 
1·HClO4 (32 mg, 0.12 mmol) in CH3NO2/H2O (95/5 v/v, 1.0 M) was added acrolein (1.0 
mL, 15 mmol), and 2,3-dimethylbutadiene (0.50 mL, 5 mmol). The solution was stirred at -
10 oC for 11 hr, then directly placed onto a silica gel column and eluted with 3% 
Et2O/pentane, affording the title compound as a colorless oil in 94% yield (745 mg, 92% 
                                                
7 Marvel, C. S.; Woolford, R. G. J. Org. Chem. 1958, 23, 1658. 
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ee).  Product ratios were determined by GLC (Bodman β-DM column, 80 oC isotherm 40 23 
psi) tr =  16.2 min, 16.7 min.  IR (CH2Cl2) 2926, 2837, 2714, 1722, 1494, 1444 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 9.78 (s, 1H, CHO), 7.40-7.23 (m, 5H, ArH), 6.16-6.12 (m, 1H, 
PhC=CH), 2.64-2.50 (m, 5H), 2.23-2.15 (m, 1H), 1.90-1.79 (m, 1H). 13C NMR (100 MHz, 
CDCl3) δ 204.2, 141.6, 136.8, 128.2, 126.9, 125.0, 122.0, 45.7, 26.0, 25.0, 22.6; HRMS (CI) 
exact mass calcd for (C13H19N2OCl) requires m/z 186.1045, found m/z 186.1041.  1H NMR 
data are consistent with previously reported values. 5 
 
Methyl (1S, 6S)-6-formyl-3,4-dimethylcyclohex-3-ene-1-carboxylate.  To a -20 
°C solution of 1·HClO4 (29.8 mg, 0.14 mmol) and (E)-methyl-4-oxo-butenoate (135 µL, 2.1 
mmol) in CH3CN/H2O (95/5 v/v, 1.0 M) was added 2,3-dimethylbutadiene (89 mg, 0.68 
mmol).  The solution was stirred at -20 oC for 23 hr, then directly isolated by flash 
chromatography in 5% ether/pentane to afford the title compound as a colorless oil in 88% 
yield (114 mg, 0.61 mmol, 95% ee).  Enantiomeric excess was determined by GLC 
(Bodman β-DM column, 95 ºC isotherm, 23 psi) tr = 61.5 min and 62.9 min.    IR (CH2Cl2) 
2926, 2837, 2714, 1722, 1494, 1444 cm-1; 1H NMR (400 MHz, CDCl3) δ 9.78 (s, 1H, CHO), 
7.40-7.23 (m, 5H, ArH), 6.16-6.12 (m, 1H, PhC=CH), 2.64-2.50 (m, 5H), 2.23-2.15 (m, 
1H), 1.90-1.79 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 204.2, 141.6, 136.8, 128.2, 126.9, 
125.0, 122.0, 45.7, 26.0, 25.0, 22.6; HRMS (CI) exact mass calcd for (C13H19N2OCl) 
requires m/z 186.1045, found m/z 186.1041.  (1R)-4-phenyl-3-cyclohexene-1-ol:  IR 
(CH2Cl2) 3374, 3289, 2918, 2860, 1444 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.41-7.39 (d, J 
= 7.6 Hz, 2H, o-ArH), 7.34-7.31 (t, J = 7.7 Hz, 2H, m-ArH), 7.26-7.22 (m, 1H, p-ArH), 6.13 
(br, 1H, PhC=CH), 3.66-3.58 (m, 2H, CH2OH), 2.58-2.41 (m, 2H), 2.40-2.31 (m, 1H), 2.05-
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1.83 (m, 3H), 1.72-1.68 (s, 1H), 1.50-1.41 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 142.1, 
136.5, 128,2, 126.6, 124.9, 123.3, 67.6, 35.9, 28.8, 26.8, 25.7; HRMS (CI) exact mass calcd 
for (C13H19N2OCl) requires m/z 188.1201, found m/z 188.1203.  
 
Methyl (1S,6S)-6-formyl-3-methylcyclohex-3-ene-1-carboxylate.  To a  
–10 °C solution of 1·HClO4 (29.8 mg, 0.14 mmol) and (E)-methyl-4-oxo-butenoate (135 µL, 
2.1 mmol) in CH3CN/H2O (95/5 v/v, 1.0 M) was added isoprene (89 mg, 0.68 mmol).  The 
solution was stirred at -10 oC for 23 hr, then directly isolated by flash chromatography in 5% 
ether/pentane to afford the title compound as a colorless oil in 81% yield (114 mg, 0.61 
mmol, 95% ee).  Enantiomeric excess was determined by GLC (Bodman β-DM column, 90 
ºC isotherm, 23 psi) tr = 43.3 min and 45.4 min.    IR (CH2Cl2) 2926, 2837, 2714, 1722, 
1494, 1444 cm-1; 1H NMR (400 MHz, CDCl3) δ 9.78 (s, 1H, CHO), 7.40-7.23 (m, 5H, ArH), 
6.16-6.12 (m, 1H, PhC=CH), 2.64-2.50 (m, 5H), 2.23-2.15 (m, 1H), 1.90-1.79 (m, 1H). 13C 
NMR (100 MHz, CDCl3) δ 204.2, 141.6, 136.8, 128.2, 126.9, 125.0, 122.0, 45.7, 26.0, 25.0, 
22.6; HRMS (CI) exact mass calcd for (C13H19N2OCl) requires m/z 186.1045, found m/z 
186.1041.  (1R)-4-phenyl-3-cyclohexene-1-ol:  IR (CH2Cl2) 3374, 3289, 2918, 2860, 1444 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.41-7.39 (d, J = 7.6 Hz, 2H, o-ArH), 7.34-7.31 (t, J = 
7.7 Hz, 2H, m-ArH), 7.26-7.22 (m, 1H, p-ArH), 6.13 (br, 1H, PhC=CH), 3.66-3.58 (m, 2H, 
CH2OH), 2.58-2.41 (m, 2H), 2.40-2.31 (m, 1H), 2.05-1.83 (m, 3H), 1.72-1.68 (s, 1H), 1.50-
1.41 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 142.1, 136.5, 128,2, 126.6, 124.9, 123.3, 67.6, 
35.9, 28.8, 26.8, 25.7; HRMS (CI) exact mass calcd for (C13H19N2OCl) requires m/z 
188.1201, found m/z 188.1203.  
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Methyl (2S,3S)-3-formylbicyclo[2.2.2]oct-5-ene-2-carboxylate.  To a 4 ºC solution 
of 1·TfOH (32 mg, 0.12 mmol) and (E)-methyl-4-oxo-butenoate (135 µL, 2.1 mmol) in 
CH3CN/H2O (95/5 v/v, 1.0 M) was added cyclohexadiene (238 µL, 2.5 mmol).  The solution 
was stirred for 23 h, after which time the reaction mixture was applied directly to a silica gel 
column and eluted with (5% ether/pentane) to afford the title compound as a colorless oil in 
92% yield (280 mg, 2.06 mmol); 5:1 endo:exo; 97% ee.  Product ratios were determined by 
GLC (Bodman β-DM column, 90 °C isotherm 5 min, ramp 10ºC/min to 110 ºC, 23 psi) endo 
isomers tr = 32.2 min and 33.5 min, exo isomers tr = 32.9 min and 35.4 min.   IR (CH2Cl2) 
2926, 2837, 2714, 1722, 1494, 1444 cm-1; 1H NMR (400 MHz, CDCl3) δ 9.78 (s, 1H, CHO), 
7.40-7.23 (m, 5H, ArH), 6.16-6.12 (m, 1H, PhC=CH), 2.64-2.50 (m, 5H), 2.23-2.15 (m, 
1H), 1.90-1.79 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 204.2, 141.6, 136.8, 128.2, 126.9, 
125.0, 122.0, 45.7, 26.0, 25.0, 22.6; HRMS (CI) exact mass calcd for (C13H19N2OCl) 
requires m/z 186.1045, found m/z 186.1041.   
 
[(2S, 3S)-3-Formylbicyclo[2.2.1]hept-5-en-2-yl]-methyl benzoate and [(2S, 3S)-3-
Formylbicyclo[2.2.1]hept-5-en-2-yl]-methyl benzoate.  Prepared according to the general 
procedure with 1•HClO4 (34 mg, 0.13 mmol) and (E)-4-benzyloxy-but-2-enal (166 mg, 1.36 
mmol) in THF/H2O (95/5 v/v, 1.0 M) at +4 °C.  Reaction was complete 11 h after addition 
of cyclopentadiene (329 µL, 3.99 mmol).  Direct isolation by silica gel chromatography 
(10% EtOAc/hex) gave 17 as a colorless oil in 89% yield (1.0:1.3  endo:exo; endo 95% ee; 
exo 91% ee).  Product ratios were determined by GLC (Bodman β-DM column, 170 °C, 23 
psi); exo isomers tr = 34.6 min and 35.7 min, endo isomers tr = 37.8 min and 38.8 min.  1H 
NMR data are consistent with reported values.4 
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Methyl (1S,6S)-6-formyl-3-phenylcyclohex-3-ene-1-carboxylate.  Prepared 
according to the general procedure with 1·HClO4 (34 mg, 0.13 mmol) and (E)-methyl-4-
oxo-butenoate (166 mg, 1.36 mmol) in CH3CN/H2O (95/5 v/v, 1.0 M) at -20 °C.  Reaction 
was complete 24 h after addition of 2-phenyl-1,3-butadiene.8 Direct isolation by silica gel 
chromatography (10% EtOAc/hex) gave 18 as a colorless oil in 87% yield ((89 mg, 0.68 
mmol,  90% ee).  Product ratios were determined by GLC (Bodman β-DM column, 135 °C, 
40 psi); tr = 94.5 min and 96.9 min.  1H NMR data are consistent with reported values.4 
 
 [(1S,6S)-6-formyl-3-phenylcyclohex-3-en-1-yl]methyl benzoate.  To a +4 °C 
solution of 1·TfOH (29.8 mg, 0.14 mmol) and (E)-4-benzyloxy-but-2-enal (135 mg, 2.1 
mmol) in CH3CN/H2O (95/5 v/v, 1.0 M) at +4 °C.  The solution was stirred at +4 oC for 12 
hr, then directly placed onto a silica gel column and eluted with 5% EtOAc/hex affording 
the title compound as a colorless oil in 86% yield (114 mg, 0.61 mmol, 90% ee).  Product 
ratios were determined by HPLC analysis of of alcohol, obtained by NaBH4 reduction of the 
aldehyde using Chiracel OD-H column (1.6 × 25 cm) and Chiralcel OD guard (1.6 × 5 cm); 
2% ethanol in hexanes, 1.0 mL/min; tr = 46.3 min and 54.7 min.  1H NMR data are 
consistent with previously reported values.4 
 
Benzyl (1S,6R)-6-formylcyclohex-2-en-1-ylcarbamate.  To a -20 °C solution of 
1·TfOH (27 mg, 0.11 mmol) in THF/H2O (95/5 v/v, 1.0 M) was added acrolein (102 µL, 
1.53 mmol), and N-Cbz-amino-1,3-butadiene (60 mg, 0.51 mmol).  The solution was stirred 
                                                
8 Marvel, C. S.; Woolford, R. G. J. Org. Chem. 1958, 23, 1658. 
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for 6 h then directly purified by silica gel chromatography (10% EtOAc/hex) affording the 
20 as a white solid in 86% yield (85 mg, 12 mmol); 6:1 endo:exo; 95% ee.  Product ratios 
were determined by GLC (Bodman β-DM column, 160 °C initial temp, 30 psi); endo 
isomers tr = 103.0 min and 106.2 min, exo isomers tr = 94.0 min and 96.1 min. 1H NMR data 
are consistent with previously published spectra.5  
 
Benzyl (1S,5S,6R)-6-formyl-5-methylcyclohex-2-en-1-ylcarbamate (21).  To a -10 
°C solution of 1·HClO4 (29.8 mg, 0.14 mmol) and (E)-crotonaldehyde (135 µL, 2.1 mmol) 
in CH3CN/H2O (95/5 v/v, 1.0 M)   was added N-Cbz-amino-1,3-butadiene (89 mg, 0.68 
mmol).  The solution was stirred at -10 oC for 9 hr, then directly placed onto a silica gel 
column and eluted with 5% EtOAc/hex affording the title compound as a colorless oil in 
70% yield (114 mg, 0.61 mmol, 91% ee).  Product ratios were determined by HPLC analysis 
of the alcohol, obtained by NaBH4 reduction of the aldehyde using Chiracel OD-H column 
(1.6 × 25 cm) and Chiralcel OD guard (1.6 × 5 cm); 2% ethanol in hexanes, 1.0 mL/min; tr = 
25.5 min and 28.3 min.    1H NMR data are consistent with reported values.4 
 
Benzyl (1S,6R)-6-formylcyclohex-2-en-1-ylcarbamate.  To a -20 °C solution of 
1·HClO4 (27 mg, 0.11 mmol) in CH3CN/H2O (95/5 v/v, 1.0 M) was added (E)-methyl-4-
oxo-butenoate (102 mg, 1.53 mmol) and N-Cbz-amino-1,3-butadiene (260 mg, 1.71 mmol).  
The solution was stirred for 9 h then directly purified by silica gel chromatography (10% 
EtOAc/hex) affording 22 as a white solid in 71% yield (85 mg, 1.2 mmol); 4:1 endo:exo; 
97% ee.  Product ratios were determined by HPLC analysis of the alcohol, obtained by 
NaBH4 reduction of the aldehyde using Chiracel AD column (1.6 × 25 cm) and Chiralcel 
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AD guard (1.6 × 5 cm); 7% isopropanol in hexanes, 1.0 mL/min; tr = 30.3 min and 34.3 min.  
1H NMR data are consistent with published spectra.5  
 
Benzyl (1S,5S,6R)-6-formyl-5-methylcyclohex-2-en-1-ylcarbamate.  To a -10 °C 
solution of 1·HClO4 (29.8 mg, 0.14 mmol) and (E)-4-benzyloxy-but-2-enal (135 mg, 2.1 
mmol) in THF/H2O (95/5 v/v, 1.0 M) was added N-Cbz-amino-1,3-butadiene (89 mg, 0.68 
mmol).  The solution was stirred at -10 oC for 17 hr, then directly placed onto a silica gel 
column and eluted with 5% EtOAc/hex affording the title compound as a colorless oil in 
83% yield (114 mg, 0.61 mmol 10:1 endo:exo, 99% ee).  Product ratios were determined by 
HPLC analysis of the alcohol, obtained by NaBH4 reduction of the aldehyde using Chiracel 
OD-H column (1.6 × 25 cm) and Chiralcel OD guard (1.6 × 5 cm); 7% isopropanol in 
hexanes, 1.0 mL/min; endo tr = 36.6 min and 52.9 min and exo tr = 41.2 min and 63.9 min).    
1H NMR data are consistent with previously reported values.4 
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Chapter 2 
Access to α-Alkylated α-Amino Acids via Asymmetric Organocatalysis 
 
Introduction 
α-Alkylated α-amino acids are particularly valuable as components of natural products,1 
pharmaceutical targets,2  and probes of peptide conformation and enzyme activity.3  While 
the applications of these non-natural amino acids continue to expand in biology, medicine, 
materials science, and chemical synthesis, there are limited catalytic asymmetric methods to 
produce fully-substituted α-amino acids.4,5  Using LUMO-lowering iminium catalysis, 
conjugate addition of silanyloxy oxazoles to α,β-unsaturated aldehydes provides an 
asymmetric catalytic method by which to access these acids. 
The utility of non-natural amino acids has been demonstrated in biological systems as 
their incorporation into peptides and pharmaceutical agents alters activity and allows 
scientists to probe enzymes.  Promising as catalysts, they are implicated in the evolution of 
homochirality required for life on earth.  The added substitution at the α-carbonyl position 
compared to naturally occurring amino acids blocks the epimerization at that center 
commonly observed when an enolizable hydrogen is present.  The greater stability of these 
compounds extends to include increased rigidity when they are incorporated into peptides 
and other biological polymers and oligomers.3  In drug targets, the fully-substituted amino 
acid exhibits better metabolic stability such that more of the treatment reaches its target. 
 
 
Figure 1.  Sampling of biologically active compounds with fully-substituted amino motif 
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Background 
To date, classical resolution of a racemate is still one of the simplest methods to produce 
the enantiopure amino compound on large scale, despite the maximum 50% yield.6  In the 
example shown in equation 1, (R)-mandelic acid yields (S)-ethyl 2-amino-2-(4-
bromophenyl)propanoate after recrystallization.  Another common route of access to desired 
unnatural amino acids is the diastereoselective alkylation of auxiliary-derived 
intermediates.7  Again, a stoichiometric amount of an enantiopure compound is required to 
differentiate enantiomers by the formation of energetically distinct diastereomeric 
complexes.  In the widely applicable synthetic sequence developed by Seebach and 
coworkers, the enantiopure trisubstituted amino acid is condensed with bulky 
trimethylacetaldehyde, and the bicyclic oxazolidone is alkylated in what is termed self-
reproducing chirality (eq. 2).  Then, the desired diastereomer is purified away from the 
undesired minor product and then liberated by acid hydrolysis of the N,O-acetal. 
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A large number of groups have explored chiral phase transfer catalysis to access α-
alkylated amino acids.8  While successful in the enantioselective synthesis of monoalkylated 
glycine derivatives, the alkylation of tertiary centers to produce quaternary α-amino acids is 
not as selective or high-yielding.9  In 1989, O’Donnell reported the asymmetric phase-
transfer alkylation of Schiff bases using cinchona alkaloid-derived quaternary ammonium 
salts and extended the methodology a few years later from glycine-derived imines to 
alanine-derived imines to yield quaternary amino acids (eq. 3).10  One of the best examples 
uses the same imine reported by O’Donnell, but modifying the catalyst from N-benzyl to N-
anthracenyl-methyl and switching the solvent from dichloromethane to toluene raises the 
selectivity of alkylation with benzyl bromide from 44% ee to 87% ee.11   
N
Ot-Bu
O
Me
Cl
N
Ot-Bu
O
Cl
RMe
10 mol%
N
HO N
Cl
R–X
K2CO3/KOH, CH2Cl2
23 °C, 15 h
R–X: BnBr
p-F-BnBr
CH2=CHCH2Br
44% ee, 80% yield
50% ee, 84% yield
36% ee, 78% yield
(3)
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Faced with a maximum enantioselectivity which is still less than 90% for an already 
limited substrate scope, the best way to develop a method which would allow modulation of 
both R groups is to add each one separately.  Using a C2-symmetric binapthyl-based 
quaternary ammonium salt designed for the monoalkylation of a glycine ketimine, Maruoka 
and coworkers demonstrated that high enantioselectivities and good yields could be 
achieved in the phase-transfer catalyzed sequential bis-alkylation of glycine aldimines (eq. 
5).12  As the order of addition of the allyl or benzyl bromide alters the enantiomeric series of 
the product, it is likely that a chiral ammonium enolate is formed after the first alkylation, 
and that intermediate then attacks the second alkylating agent with high enantioselectivity.  
This methodology forms a single quaternary stereocenter in high enantioselectivity, but the 
groups that can be added are limited to accessible alkylating agents. 
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Another catalytic asymmetric method to form α-alkylated-α-amino acids is asymmetric 
allylic alkylation.5,6  In 1999, Trost and Azria reported the alkylation of 4-substituted-2-
phenyloxazolones with allylic esters using the bis-2-diphenylphosphino-benzamide of 
(R,R)-1,2-diaminocyclohexane as the palladium ligand (eq. 6).  While some of the branched 
product bearing a stereocenter adjacent to the quaternary center is observed, the best 
enantioselectivity with this palladium-based catalytic system is only 40%.  Switching to a 
molybdenum-based system with an acylpyridine of 1,2-diaminocyclohexane as the ligand 
allows for optimization to yield the branched amino acid as the major product (eq. 7).  In 
fact, the benzoyl-protected quaternary amino acid is synthesized directly via a one-pot 
procedure in good enantioselectivity and excellent yield as potassium carbonate in methanol 
can simply be added to the crude reaction mixture to affect hydrolysis of the oxazolone.  
However, even with extensive optimization, this asymmetric alkylation reaction is not 
completely regioselective and requires an aryl moiety on the allylating agent to operate 
successfully. 
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Preliminary Results 
Our laboratory has designed amine catalysts which activate α,β-unsaturated carbonyls 
via the reversible formation of chiral iminium ions.13  Based upon this LUMO-lowering 
mode of electrophile activation, we envisioned that protected quaternary α-amino acids 
could be accessed by an organocatalytic conjugate addition of silanyloxy oxazoles to α,β-
unsaturated aldehydes (eq. 1).  The added utility of this 1,4-addition manifold is the 
regioselective creation of a tertiary stereocenter vicinal to the quaternary amino center.6 
Scheme 1.  Quaternary amino acids via organocatalytic conjugate addition of oxazoles   
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Increasing the reactivity of the nucleophile by using the known 4-methyl-2-phenyl 
silanyloxy oxazole, Sean Brown found that 10 mol% of the second-generation t-butyl benzyl 
imidazolidinone catalyst provided excellent enantioselectivity in the formation of the 
protected quaternary α-amino acid as a single diastereomer (eq. 5).  However, these adducts 
are highly sensitive to acid, and the trace acid in silica gel is enough to decompose a 
significant portion of the product during column chromatography.  From alumina to base-
treated silica as the immobile phase, the maximum yield observed is 70%.  Furthermore, 
despite trying a large number of enals, oxazoles, and other heteroaromatic nucleophiles, the 
selectivity of the product from only one other aldehyde with only the 4-methyl oxzaole 
could be determined as assay development proved extremely difficult.  For adducts with a 
molecular weight too high to attempt a GLC assay, using the HPLC was attempted, but 
sodium borohydride (NaBH4) reduction of these aldehyde-bearing protected amino acids in 
methanol produced an unusable mix of undetermined products.  Faced with these 
difficulties, the project was put on hold. 
N
O
OTIPS
Me
Ph
OMe
N
O
O
Ph
Me
O
Me
10 mol%
CH3CN, 2 eq. H2O, –40 °C
96% ee
>20:1 dr
70% yield
•TFA
(5)
N
N
H
O Me
Me
Me
Me
Ph
 
 
A. Asymmetric Conjugate Additions of Oxazoles to α,β-Unsaturated Aldehydes 
One of the first studies conducted upon taking up this project was the reevaluation of 
reaction efficiency and selectivity with amines 1-3.  In the conjugate addition of 4-methyl 
silanyloxy oxazole 4 to (E)-crotonaldehyde, proline exhibits poor selectivity for latent 
amino acid 5 (Table 1, entry 1, 32% ee).  Although dimethyl imidazolidinone 1•TFA 
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significantly improves enantioselectivity (entry 2, 65% ee), both catalysts affect substantial 
hydrolysis of the starting oxazole to the less-reactive oxazolone.  As there is a marked 
increase in reactivity and selectivity between first-generation catalyst 1 and second-
generation catalyst 2 due to the fact that imidazolidinone catalyst 2 forms a more reactive 
iminium ion intermediate (see section I-C), it is not surprising that tert-butyl benzyl catalyst 
2•TFA13,14 provides synthetically useful levels of enantioenriched aldehyde (entry 3, 83% 
yield, 93% ee).   
In the conjugate addition of silanyloxy oxazole 4 to (E)-crotonaldehyde, tryptophan-
derived 3 is the optimal imidazolidinone catalyst for the generation of aldehyde-bearing 
quaternary α-amino acid 5 (Table 1). The higher enantioselectivity imparted by catalyst 3 is 
attributed to the greater ability of indole versus benzyl to participate in a cation–π 
interaction with the α,β-unsaturated iminium.  Proline exhibits poor activity and selectivity 
for the formation of protected amino acids (entry 4, 5% yield, 23% ee).  There is no 
detectable background reaction in the absence of catalyst (entry 5). 
Table 1.  Choice of Amine Catalyst is Critical 
N
N
H
O Me
Me
Me
Me
N
H
N
N
H
O Me
Me
Me
N
N
H
O Me
Me
Me
Me
Ph Ph
catalyst 1 catalyst 2 catalyst 3
14
26
68
73
ee (%)
1
2
3
4
32
65
95
97
D-proline
1•TFA
2•TFA
3•TFA
N
O
OTIPS
Me
Ph
OMe
N
O
O
Ph
Me
O
Me
catalyst yield (%)entry
5 mol% catalyst
CH3CN, 2 eq. H2O
–40 °C, 10 h 54
5:1
20:1
>20:1
>20:1
38
39
2
2
hydrolysis (%) syn:anti
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Whereas only one diastereomer (5) is observed in the conjugate addition of 4-methyl 
silanyloxy furan 4 to (E)-crotonaldehyde with either trifluoroacetic acid (TFA) as co-
catalyst, the diastereoselectivity of other α,β-unsaturated aldehydes showed a marked 
dependence on the identity of the acid co-catalyst (Table 2).  In the organocatalyzed addition 
of 4 to trans-2-pentenal, high diastereoselection in the formation of 6 is achieved with acids 
with the largest conjugate bases (entry 2, trichloroacetic acid (TCA), >20:1; entry 4, 
dibromoacetic acid (DBA), 16:1), while none is observed with diminutive cyanoacetic acid 
(entry 5, 1:1).  Intimate association of the negatively charged conjugate base with the 
positively charged iminium ion may account for the variation in the facial selectivity with 
co-catalyst size rather than acidity, but there is no data as yet which pinpoints the location of 
the conjugate base of the iminium ion.  Interestingly, while the diastereoselectivity ranges 
from 1:1 to greater than 20:1 and the yield from 16-52% for the oxazole addition into 2-
pentenal, the enantioselectivities are all 97% for a variety of less-acidic co-catalysts, with 
the exception of poorly reactive cyanoacetic acid. 
Table 2.  Effect of the Acid Co-catalyst on Diastereoselectivity 
22
52
25
28
16
ee (%)
1
2
3
4
5
97
97
97
97
93
TFA
TCA
DCA
DBA
cyanoacetic acid
Ph
Et
O
MeN
O
O
N
O
OTIPS
Me
Ph
OEt
yield (%)entry
10 mol% 3•HX
CH3CN, 2 eq. H2O
–40 °C
HX dr
4:1
>20:1
5:1
16:1
1:1
64
 
As careful selection of both the chiral amine and acid co-catalyst is required for the 
diastereoselective as well as enantioselective generation of quaternary α-amino acids, the 
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effect of the acid co-catalyst on the original conjugate addition of oxazole 4 to 
crotonaldehyde was reassessed (Table 3).  Increasing the acidity of the co-catalyst to TfOH 
causes hydrolysis and diminished yield and selectivity for protected amino acid 5 (entry 5, 
16% hydrolysis, 83% ee, 34% yield).  TFA and 2,4-dinitrobenzoic acid (2,4-DNBA) 
maintain greater than 90% ee but result in slower conversion to product (entries 6 and 7, 
65% and 12% yield).  Not only is the rate of reaction much slower with TFA than TCA, the 
enantioselectivity is higher.  Note that there is no detectable background reaction in the 
absence of catalyst.  
Table 3.  High selectivities with TCA transfer to original addition with crotonaldehyde 
34
65
96
12
0
ee (%)
1
2
3
4
5
83
97
98
94
ND
3•TfOH
3•TFA
3•TCA
3•2,4-DNBA
none
N
O
OTIPS
Me
Ph
OMe
N
O
O
Ph
Me
O
Me
catalyst yield (%)entry
5 mol% catalyst
CH3CN, 2 eq. H2O
–40 °C, 10 h 54
>20:1
>20:1
>20:1
>20:1
ND
syn:anti
16
1
2
1
0
hydrolysis (%)
 
It is important to note that each reaction component is essential for optimum results. 
Although the omission of H2O only lowers the enantioselectivity by 1%, conversion is 
severely decreased when comparing 2 eq. H2O (100% conv.), 1 eq. H2O (81% conv.), and 0 
eq H2O (41% conv.).  This addition of 2 eq. H2O is required as the water formed from 
condensation of the amine catalyst with the aldehyde substrate becomes trapped as TIPSOH 
upon desilylation of the oxazolone after the rate-determining conjugate addition.14c  In this 
form, the water is unavailable to hydrolyze product-bound catalyst as shown by the catalytic 
cycle shown in Figure 2. 
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Figure 2.  Catalytic cycle of silanyloxy oxazole conjugate addition to enals 
N
N
O Me
t-Bu
Ar
R
X
H2O
OR
•HX
N
N
MeO
t-Bu
N
O R
Me
N
O
OTIPS
Me
Ph
N
O
O
Me
Ph
R
O
Ph
O
(i-Pr)3Si
H2O
N
N
H
O Me
t-Bu
(i-Pr)3SiOH
N
N
MeO
t-Bu
N
O R
Me
Ph
O
Ar
Ar
Ar
X
X
H2O
 
Examination of aldehyde scope of the conjugate addition of 4-methyl oxazole 4 
demonstrates that the 3•TCA organocatalytic system tolerates considerable steric variation at 
the enal β-position (Table 4, entries 1-4, R = Me, Et, i-Pr, Me2 96-98% ee, 15 to >20:1 dr).  
For aldehydes that form more conjugated, stable iminium intermediates, complete 
conversion requires higher reaction temperature (entry 5, R = Ph, 92% ee, –20 °C), and 
reversal of diastereoselectivity is observed.14c  As this is result is not observed for the 
sterically similar iPr-substituted enal, it is likely that there is a π-π interaction with the Ph of 
the enal which disrupts a similar interaction with the Ph of the approaching silanyloxy 
oxazole.  In entry 6, organocatalyzed addition produces a quaternary α-amino acid with a 
vicinal tertiary center bearing a protected alcohol and a pendant aldehyde in 94% ee, 10:1 dr, 
and 85% yield.  Acetonitrile (CH3CN) is the only solvent that combines complete 
conversion with enantioselectivities greater than 90% for all these substrates. 
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Table 4.  Organocatalyzed oxazole conjugate addition to representative α,β-unsaturated 
aldehydes 
>20:1
>20:1
15:1
NA
1:12
10:1
syn:anti
10
13
13
15
23
9
time (h)
90
84
75
82
93
85
% eea
1
2
3
4
5
6
98b
96
96
97c
92c,d
94
–40
–40
–30
–40
–20
–30
temp (°C)
Me
Et
i-Pr
gem-Me2
Ph
CH2OBz
N
O
OTIPS
Me
Ph
OR
N
O
O
Ph
R
O
Me
R % yieldentry
5 mol% 3•TCA
CH3CN, 2 eq. H2O
4
 
aProduct ratios by chiral GC or HPLC.  bAbsolute and relative configuration assigned by 
single-crystal X-ray analysis of derivative (SPB).  cAbsolute and relative configuration 
assigned by chemical correlation to a known compound.  d5 mol% TFA as co-catalyst. 
 
Although the main impetus of this methodology is to provide access to quaternary α-
amino acids, in order to achieve the broadest substrate scope, the ability to couple a 4-
hydrogen substituted glycine-derived silanyloxy oxazole would form a tertiary α-amino 
center (or a secondary amino stereocenter).  Of course, a concern with the formation of such 
products is that this α-carbonyl hydrogen is acidic and makes this stereocenter prone to 
epimerization.  Different silyl groups were tested in order to ascertain whether 
triisopropylsilyl (TIPS) still provides the best combination of reactivity and selectivity 
compared to tert-butyldimethylsilyl (TBS) or triethylsilyl (TES) protecting groups for these 
5-oxy oxazoles.  After 12 hours at –40 °C, TIPS protection leads to the highest conversion 
(67%) with TBS and TES providing 39% and 13% conversion, respectively.  The maximum 
diastereoselectivity observed is 4:1 with either TCA or TFA as the acid co-catalyst.   
Unfortunately, there is a significant amount of hydrolysis of even the TIPS oxazole to 
the less reactive oxazolone at this temperature.  This is likely caused by the fact that 
unsubstituted oxazole (5) is significantly less soluble at low temperatures than the 
75 
 
corresponding 4-methyl triisopropyl silanyloxy oxazole (4).  In comparing other solvents to 
CH3CN, conducting the conjugate addition of 5 to crotonaldehyde in acetone greatly 
increases conversion without as significantly decreasing enantioselectivity of aldehyde 7.  
Comparing 2:1 and 1:1 mixtures of CH3CN:acetone along with TCA versus TFA and 1 or 2 
equivalents water at –60 °C shows that the best overall conversion and enantioselectivity is 
achieved with the greater ratio of CH3CN, TCA, and 1 equivalent water (Table 5, entry 7).  
However, on large scale the yield reaction in acetone does contain the hydrolyzed oxazolone 
of 5 according to the crude 1H NMR, something that is not observed with oxazole 4, and the 
large scale reaction in CH3CN alone operates more efficiently on large scale. 
Table 5.  Optimization of reaction conditions for unsubstituted silanyloxy oxazole 
TIPSO
Ph
N
O
Me O
N
O
O
Ph
Me
CHO
5 mol% catalyst 3, 5 mol% HX
X eq. H2O, solvent, –60 °C
1.0 eq. 3.0 eq.
entry conv. (%) ee (%)HX solvent
6
eq. H2O
MeCN:acetone
(1:1, 0.25 M)
MeCN:acetone
(2:1, 0.33 M)
MeCN:acetone
(1:1, 0.25 M)
MeCN:acetone
(2:1, 0.33 M)
95/94
91/88
96/94
91/90
95/93
95/91
97/95
96/94
88
75
82
73
96
--
--
--
85
73
85
69
85
93
92
93
43
58
47
53
28
53
31
55
TCA
TFA
TCA
TFA
TCA
TFA
TCA
TFA
2
2
2
2
1
1
1
1
4h 20h 29h
1
2
3
4
5
6
7
8
7
 
More extensive variation on the oxazole component further expands the synthetic utility 
of this organocatalytic transformation (Table 6).  When R2 is isopropyl, a single enantiopure 
protected amino acid is produced (entry 2, >99% ee, >20:1 dr, 90% yield).   Both 4-phenyl 
and 4-benzyl substituted oxazoles add with excellent selectivities (entry 3, R=Ph, 96% ee, 
10:1 dr, 85% yield; entry 4, R=Bn, 97% ee, >20:1 dr, 96% yield).  Exchange of the 2-phenyl 
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for a 2-trifluoromethyl (CF3) group at R1 does not diminish the enantioselectivity observed 
with 4-benzyl oxazoles (entries 4 and 5, 97% ee).  The conjugate addition of the 4-hydrogen 
substituted silanyloxy oxazole provides 96% ee, 89% yield, and a crude 9:1 dr; however, as 
the tertiary α-amino center epimerizes upon chromatography, the isolated dr is only 3:1 
(entry 6).   It is important to note that no 1,2-addition products are observed for the 
organocatalyzed conjugate addition of any aldehyde or oxazole substrates,13c,14 and all 
adducts are formed in greater than 90% enantioselectivity. 
Table 6.  Various substituents on oxazole nucleophile provide high enantioselectivities 
N
O
OTIPS
R2
R1
OMe
N
O
O
R1
Me
O
R2
5 mol% 3•TCA
CH3CN, 2 eq. H2O
>20:1
>20:1
10:1
>20:1
 9:1
   3:1b
syn:anti
90
90
85
96
78
89
% eea
98
>99
96
97
97
96
10
2
23
13
8
7
time (h)
–40
–20
–30
–40
–40
–40
temp (°C) % yield
1
2
3
4
5
6
entry oxazole
R1 =    R2 =
Ph
Ph
Ph
Ph
CF3
Ph
Me
i-Pr
Ph
Bn
Bn
H
 
aProduct ratios determined by chiral GC or HPLC.  bCrude dr = 9:1. 
Considering the possible trajectories of oxazole addition shows that a combination of 
energetically favorable interactions leads to the observed diastereoselectivity (Fig. 3).  The 
lowest energy approach places the methyl (Me) and silanyloxy (OTIPS) moieties of the 
oxazole in the open quadrant of the iminium C–C double bond and accesses a stabilizing π-π 
interaction between the indole of the catalyst and the phenyl (Ph) of the oxazole.  In the 
middle of Fig. 3, this favorable interaction with the indole is replaced by steric repulsion of 
the oxazole methyl and a possible gauche interaction with the iminium methyl.  The worst 
trajectory clashes the iminium methyl with the oxazole ring itself.  Unraveling the lowest 
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energy conjugate addition adduct leads to the observed stereochemistry as proven by x-ray 
crystallography. 
Figure 3.  Proposed transition state leading to observed diastereoselectivity 
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While 5 mol% of imidazolidinone 3•TCA is routinely employed in this investigation, 
catalyst loading as low as 0.5 mol% maintains  >99.5% ee, >20:1 dr, and 76% yield of 8 
(Table 7).  Hydrolysis of the silanyloxy oxazole to the less-reactive oxazolone at longer 
reaction times accounts for the reduction in yield between 1 and 0.5 mol% amine catalyst 3 
(entries 4 and 5, 87% yield and 76% yield).  Conjugate addition of the unsilylated 4-methyl 
oxazolone results in a 93% ee compared to 98% ee with 4-methyl silanyloxy oxazole 4.  In 
addition, these studies reveal that the observed change in reaction rate as a function of 
catalyst loading is consistent with first-order kinetics in the catalyst•TCA component.  
Table 7.  Effect of catalyst loading on organocatalyzed alkylations 
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Ph
Me
O
i-PrN
O
O
N
O
OTIPS
i-Pr
Ph
OMe
mol% 3•TCA
CH3CN, 2 eq. H2O
–20 °C
>20:1
>20:1
>20:1
>20:1
>20:1
dr
1
2
5
9
19
time (h)
92
90
89
87
76
% eea
1
2
3
4
5
>99.5
>99.5
>99.5
>99.5
>99.5
10
5
2
1
0.5
% yieldmol% 3•TCAentry
87
 
aProduct ratios determined by chiral HPLC. 
Furthermore, a sequence for unmasking these unnatural α-amino acids was developed.  
If the pendant aldehyde is not desired, decarbonylation of the conjugate addition product of 
9 and (E)-crotonaldehyde with Wilkinson’s catalyst followed by acidic hydrolysis cleanly 
provides N-benzoyl amino acid 10 in 85% overall yield (eq. 2).18  As shown in equation 3, 
treatment of the adduct of 4 and 3-methyl-2-butenal with Wilkinson’s catalyst followed by 
strong acid provides fully-deprotected quaternary amino acid 11 in 70% yield over 3 steps.18  
The only other reported synthesis of enantioenriched α-methyl-tert-leucine proceeds in only 
2% overall yield.3 
HO
t-Bu
O
NH2
Me
    CH3CN, 2 eq. H2O
    97% ee
2)    Rh(PPh3)Cl, toluene 
3)  33% HBr/AcOH, H2O
   70% overall yield
N
O
OTIPS
Me
Ph
OMe
Me
1)       5 mol% 3•TCA
(3)
4
11
HO
i-Pr
O
NHBz
Bn
    CH3CN, 2 eq. H2O
  97% ee, >20:1 dr
2)    Rh(PPh3)Cl, toluene
3) 1:2:1TFA:H2O:CH3CN
    85% overall yield
N
O
OTIPS
Bn
Ph
OMe
1)       5 mol% 3•TCA
(2)
9
10
 
In summary, iminium catalysis is a valuable platform for the development of practical 
enantioselective processes for the formation of quaternary stereocenters.  This work 
establishes the first asymmetric addition of silanyloxy oxazoles to enals to generate 
aldehydes bearing vicinal quaternary α-amino acid and tertiary carbon stereocenters in high 
selectivity and yield.  The dense functionality and defined stereochemistry of these products 
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marks them as highly useful synthetic amino acid building blocks.  It is also important to 
note that the sense of asymmetric induction observed in all cases is predicted by our 
previously described model.13,14  Moreover, these unnatural α-amino acid adducts, which are 
not currently accessible via Lewis acid catalysis, are produced under an aerobic atmosphere, 
using wet solvents and an inexpensive bench-stable catalyst. 
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Supporting Information 
 
General Information.  All solvents were used as obtained from commercial suppliers 
unless otherwise indicated.  Other commercial reagents were purified prior to use following 
the guidelines of Perrin and Armarego.9 Thin layer chromatograms (TLC) was performed on 
EM reagents 0.25 mm silica gel 60-F plates.  Visualization of the developed chromatogram 
was performed by fluorescence quenching and KMnO4 or para-anisaldehyde stain.  Organic 
solutions were concentrated under reduced pressure on a Büchi rotary evaporator.  
Chromatographic purification of products was accomplished using forced-flow 
chromatograms on Iatrobeads or Fisher 200-425 mesh Davisil (grade 643, type 150A) 
according to the method of Still.10  
1H and 13C NMR spectra were recorded on a Varian Mercury 300 (300 MHz) instrument, 
and are internally referenced to residual protio solvent signals.  Data for 1H NMR are 
reported as chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet), coupling constant (Hz), integration, and assignment.  Data for 13C 
NMR are reported as chemical shift.  IR spectra were recorded on Perkin-Elmer Paragon 
1000 spectrometer as thin films and reported in terms of frequency of absporption.  Mass 
spectra were obtained from the California Institute of Technology Microanalytical Services 
facility.  GLC was performed on Hewlett-Packard 6850 and 6890 Series gas chromatographs 
equipped with a split-mode capillary injection system and flame ionization detectors using 
the following columns:  Bodman Chiraldex β-DM (30 m × 0.25 mm) and Bodman Chiraldex 
                                                
9 Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; Fourth ed.; Butterworth-
Heinemann:  Oxford, 1996. 
2Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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Γ-TA (30 m × 0.25 mm).   High performance liquid chromatograms (HPLC) analysis was 
performed on a Hewlett-Packard 1100 Series HPLC, UV detection monitored at 254 nm, 
using a Chiralcel OD-H column (1.6 × 25 cm) and Chiralcel OD guard (1.6 × 5 cm).  
Progress of silanyloxy oxazole conjugate addition was typically monitored by TLC 
analysis or by GLC analysis of reaction aliquots. 
 
General Procedure for Amine-Catalyzed Oxazole Conjugate Addition Reaction:  
To a 2-dram vial equipped with a magnetic stir bar and charged with (2R, 5R)-5-benzyl-
2,2,3-trimethylimidazolidin-4-one, acid co-catalyst in CH3CN and 2 eq. H2O are added.  
Upon addition of an α,β-unsaturated aldehyde, reaction is cooled immediately. After stirring 
for 5 minutes in the appropriate temperature bath, the silanyloxyoxazole was added 
dropwise, and the resulting solution was stirred at constant temperature. Upon consumption 
of the oxazole (determined by TLC or by GLC conversion assay on parallel reaction with 
benzyl methyl ether as standard), the reaction mixture was then directly purified by 
chromatography in iatrobeads and fractions concentrated in vacuo to provide the title 
compounds.   
 
Enantioselectivity was determined by chiral GLC or HPLC analysis of the title 
compound or its derivative.  Absolute configurations were assigned by chemical correlation 
to the corresponding α-amino acid or by x-ray crystallography of a derivative.  
 
(3R, 4S)-3-(4-Methyl-5-oxo-2-phenyl-4,5-dihydro-oxazol-4-yl)-butyraldehyde. 
Prepared according to the general procedure with (E)-crotonaldehyde (124 µL, 1.5 mmol), 
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4-methyl-2-phenyl-5-triisopropylsilanyloxy-oxazole (0.166 g, 0.50 mmol), and 4 (14.3 mg, 
0.05 mmol) to afford the title compound as a colorless oil in 95% yield (0.117 g, 0.48 mmol) 
after chromatography on iatrobeads (2-5-8% EtOAc/hex); >20:1 syn:anti, 98% ee.  Product 
ratios were determined by GLC (Bodman β-DM column, 60 oC, 40 min; 5 oC/min gradient, 
23 psi); (3S, 4S) syn isomer tr =  41.5 min.  IR (film) 3064, 2971, 1821, 1725, 1655, 1004 
cm-1; 1H NMR (300 MHz, CDCl3) δ 9.76 (dd, J = 1.1, 2.2 Hz, 1H, CHO), 7.96 (m, 2H, 
ArH), 7.55 (m, 1H, ArH), 7.46 (m, 2H, ArH), 2.71 (m, 1H, CH2CHO), 2.63 (m, 1H, 
CHCH3), 2.40 (ddd, J = 2.2, 8.8, 17.1 Hz, 1H, CH2CHO), 1.48 (s, 3H, CH3), 0.99 (d, J = 7.1 
Hz, 3H, CHCH3).  13C NMR (300 MHz, CDCl3) δ 200.8, 180.1, 160.6, 133.1, 129.0, 128.2, 
125.7, 71.8, 45.6, 35.0, 22.0, 15.2; HRMS (FAB) exact mass calcd for (C14H15NO3) requires 
m/z 246.1130, found m/z 246.1122;  [αD] = -12.5 (c = 1.0, CHCl3). 
 
(3R, 4S)- 3-(4-Methyl-5-oxo-2-phenyl-4,5- dihydro-oxazol-4-yl)-pentanal.  
Prepared according to the general procedure with 3 (14.3 mg, 0.05 mmol), TCA (0.05 
mmol), trans-2-pentenal (124 µL, 1.5 mmol), and 4-methyl-2-phenyl-5-
triisopropylsilanyloxy-oxazole (0.166 g, 0.50 mmol) to afford the title compound as a 
colorless oil in 95% yield (0.117 g, 0.48 mmol) after chromatography on iatrobeads (2-5-8% 
EtOAc/hex); >20:1 syn:anti, 98% ee.  Product ratios were determined by GLC (Bodman β-
DM column, 60 oC, 40 min; 5 oC/min gradient, 23 psi); (3S, 4S) syn isomer tr =  41.5 min. IR 
(film) cm-1; 1H NMR (300 MHz, CDCl3) δ 9.85 (t, J = 1.9 Hz, 1H, CHO), 7.97 (m, 2H, 
ArH), 7.58 (m, 1H, ArH), 7.48 (m, 2H, ArH), 2.76 (m, 1H, CH2CHO), 2.56-2.43 (m, 2H, 
CHCH2CHO), 1.48 (s, 3H, CH3), 1.25 (m, 2H, CH2CH3) 0.99 (t, J = 7.4 Hz, 3H, CH2CH3).  
13C NMR (300 MHz, CDCl3) δ 201.2, 180.5, 160.4, 133.1, 129.0, 128.2, 125.8, 72.4, 43.4, 
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41.7, 23.3, 12.3; HRMS (FAB) exact mass calcd for (C15H17NO3) requires m/z 260.1287, 
found m/z 260.1289; [αD] = -3.2 (c = 1.0, CHCl3). 
 
(3R,4S)-4-Methyl-3-(4-methyl-5-oxo-2-phenyl-4,5-dihydro-oxazol-4-yl)-
pentanal.  Prepared according to the general procedure with 3 (14.3 mg, 0.05 mmol), TCA 
(0.05 mmol), trans-4-methyl-2-pentenal (124 µL, 1.5 mmol), and 4-methyl-2-phenyl-5-
triisopropylsilanyloxy-oxazole (0.166 g, 0.50 mmol) to afford the title compound as a 
colorless oil in 75% yield (0.38 mmol) after chromatography on iatrobeads (2-5-8% 
EtOAc/hex); >20:1 syn:anti, 96% ee.  Product ratios were determined by GLC.  IR (film) 
3065, 2962, 1820, 1725, 1655, 1003 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.90 (dd, J = 
1.4,1.9 Hz, 1H, CHO), 7.98 (m, 2H, ArH), 7.58 (m, 1H, ArH), 7.50 (m, 2H, ArH), 2.85 
(ddd, J = 1.9, 6.3, 17.7 Hz,  1H, CH2CHO), 2.65 (m, 1H, CHCH(CH3)2), 2.54 (ddd, J = 1.4, 
4.4, 17.7 Hz, 1H, CH2CHO), 1.48 (s, 3H, CH3), 0.99 (d, J = 7.1 Hz, 3H, CHCH3).  13C 
NMR (300 MHz, CDCl3) δ 201.5, 180.7, 160.1, 133.0, 129.0, 128.1, 126.0, 73.2, 44.2, 40.2, 
29.5, 23.9, 23.5, 18.0; HRMS (FAB) exact mass calcd for (C16H20NO3) requires m/z 
274.1443, found m/z 274.1456;  [αD] = -41.1 (c = 1.0, CHCl3). 
 
(4S)-3-Methyl-3-(4-methyl-5-oxo-2-phenyl-4,5-dihydro-oxazol-4-yl)-
butyraldehyde.  Prepared according to the general procedure with 3 (14.3 mg, 0.05 mmol), 
TCA (0.05 mmol), trans-3-methyl-2-butenal (124 µL, 1.5 mmol), and 4-methyl-2-phenyl-5-
triisopropylsilanyloxy-oxazole (0.166 g, 0.50 mmol) to afford the title compound as a 
colorless oil in 82% yield (0.41 mmol) after chromatography on iatrobeads (2-5-8% 
EtOAc/hex); 97% ee.  Product ratios were determined by GLC.  IR (film) 3063, 2975, 1818, 
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1716, 1657, 1002 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.85 (dd, J = 2.7, 3.3 Hz, 1H, CHO), 
7.99 (m, 2H, ArH), 7.58 (m, 1H, ArH), 7.49 (m, 2H, ArH), 2.63 (dd, J = 3.3, 14.9 Hz,  1H, 
CH2CHO), 2.43 (dd, J = 2.5, 14.9 Hz, 1H, CH2CHO), 1.51 (s, 3H, CH3), 1.30 (s, 3H, 
CH3CCH3), 1.19 (s, 3H, CH3CCH3).  13C NMR (300 MHz, CDCl3) δ 200.6, 179.7, 160.4, 
133.1, 129.0, 128.2, 125.7, 74.4, 50.9, 39.9, 22.7, 22.5, 19.5; HRMS (CI) exact mass calcd 
for (C15H17NO3) requires m/z 259.1208, found m/z 259.1205;  [αD] = -28.0 (c = 0.9, CHCl3). 
 
(3S,4S)-3-(4-Methyl-5-oxo-2-phenyl-4,5-dihydro-oxazol-4-yl)-3-phenyl-
propionaldehyde.  Prepared according to the general procedure with 3 (14.3 mg, 0.05 
mmol), TCA (0.05 mmol), trans-cinnamaldehyde (1.5 mmol), and 4-methyl-2-phenyl-5-
triisopropylsilanyloxy-oxazole (0.166 g, 0.50 mmol) to afford the title compound as a 
colorless oil in 93% yield (0.47 mmol) after chromatography on iatrobeads (2-5-8% 
EtOAc/hex); >20:1 syn:anti, 92% ee.  Product ratios were determined by GLC.  IR (film) 
3033, 2934, 1822, 1725, 1655, 1005 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.66 (t, J = 1.5 Hz, 
1H, CHO), 7.88 (m, 2H, ArH), 7.56 (m, 1H, ArH), 7.46 (m, 2H, ArH), 7.17 (m, 5H, ArH), 
3.79 (t, J = 7.2 Hz, ),  3.16 (dd, J = 1.4, 7.4 Hz,  2H, CH2CHO), 1.58 (s, 3H, CH3).  13C 
NMR (300 MHz, CDCl3) δ 200.4, 179.4, 160.8, 137.4, 129.2, 129.0, 128.6, 128.2, 128.1, 
125.8, 72.8, 46.2, 22.6; HRMS (FAB) exact mass calcd for (C19H18NO3) requires m/z 
308.1287, found m/z 308.1272;  [αD] = -154.1 (c = 2.6, CHCl3). 
 
(3R,4S)-Benzoic acid 2-(4-methyl-5-oxo-2-phenyl-4,5-dihydro-oxazol-4-yl)-4-
oxo-butyl ester. Prepared according to the general procedure with 4 (14.3 mg, 0.05 mmol), 
TCA (0.05 mmol), (E)-3-formylallyl benzoate (190 mg, 1.0 mmol), and 4-methyl-2-phenyl-
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5-triisopropylsilanyloxy-oxazole (0.166 g, 0.50 mmol) to afford the title compound as a 
colorless oil in 85% yield (0.117 g, 0.48 mmol) after chromatography on iatrobeads (2-5-8% 
EtOAc/hex); 10:1 syn:anti, 94% ee.  Product ratios were determined by GLC.  IR (film) 
3065, 2979, 1823, 1723, 1653, 1006, 713 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.87 (t, J = 
1.2 Hz, 1H, CHO), 7.91 (m, 4H, ArH), 7.55 (m, 1H, ArH), 7.42 (m, 4H, ArH), 4.35 (d, J = 
1.7 Hz, ),  4.33 (d, J = 2.5 Hz, ),  3.17 (ddd, J = 4.7, 7.1, 13.5 Hz,  1H, CHCH2), 2.96 (m, 
1H, CH2CHO), 2.69 (ddd, J = 1.7, 7.4, 18.2 Hz,  1H, CH2CHO), 1.55 (s, 3H, CH3).  13C 
NMR (300 MHz, CDCl3) δ 199.5, 179.9, 166.2, 161.1, 133.4, 133.1, 129.8, 129.4, 129.0, 
128.6, 128.2, 125.6, 69.5, 64.1, 41.6, 38.8, 22.8; HRMS (FAB) exact mass calcd for 
(C21H20NO5) requires m/z 366.1341, found m/z 366.1343;  [αD] = -67.9 (c = 1.5, CHCl3). 
 
(3R,4S)- 3-(4-Isopropyl-5-oxo-2-phenyl-4,5- dihydro-oxazol-4-yl)-
butyraldehyde.  Prepared according to the general procedure with 4 (14.3 mg, 0.05 mmol), 
TCA (0.05 mmol), (E)-crotonaldehyde (124 µL, 1.5 mmol), and 4-isopropyl-2-phenyl-5-
triisopropylsilanyloxy-oxazole (0.180 g, 0.50 mmol) to afford the title compound as a 
colorless oil in 90% yield (0.45 mmol) after chromatography on iatrobeads (2-5-8% 
EtOAc/hex); >20:1 syn:anti, 99% ee.  Product ratios were determined by GLC.  IR (film) 
3065, 2962, 1820, 1725, 1655, 1003 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.74 (dd, J = 1.4, 
2.2 Hz, 1H, CHO), 8.00 (m, 2H, ArH), 7.59 (m, 1H, ArH), 7.49 (m, 2H, ArH), 2.87 (m, 1H, 
CH(CH3)2), 2.47 (dd, J = 0.8, 4.0 Hz, 1H, CH2CHO), 2.40-2.29 (m, 2H, CH2CHO and 
CHCH3), 1.01 (sept, J = 7.0 Hz, 3H, CH(CH3)).  13C NMR (300 MHz, CDCl3) δ 200.8, 
179.1, 161.0, 133.0, 129.0 (2C), 128.2 (2C), 125.7, 78.7, 45.8, 32.0, 31.9, 16.9, 16.6, 14.4 ; 
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HRMS (EI) exact mass calcd for (C16H19NO3) requires m/z 273.1365, found m/z 273.1356;  
[αD] =  (c = 1.0, CHCl3). 
 
(3R,4S)- 3-(4-Benzyl-5-oxo-2-phenyl-4,5- dihydro-oxazol-4-yl)-butyraldehyde.  
Prepared according to the general procedure with 4 (14.3 mg, 0.05 mmol), TCA (0.05 
mmol), (E)-crotonaldehyde (124 µL, 1.5 mmol), and 4-benzyl-2-phenyl-5-
triisopropylsilanyloxy-oxazole (0.204 g, 0.50 mmol) to afford the title compound as a 
colorless oil in 96% yield (0.45 mmol) after chromatography on iatrobeads (2-5-8% 
EtOAc/hex); >20:1 syn:anti, 97% ee.  Product ratios were determined by GLC.  IR (film) 
3032, 2970, 1815, 1725, 1656, 970, 701 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.82 (dd, J = 
1.2, 2.1 Hz, 1H, CHO), 7.81 (m, 2H, ArH), 7.53 (m, 1H, ArH), 7.42 (m, 2H, ArH), 7.17 (m, 
5H, CH2ArH), 3.19 (q, J = 12.3 Hz, 2H, CH2Ar),  2.82 (m, 2H, CH2CHO), 2.52 (ddd, J = 
2.2, 9.4, 17.9 Hz, 1H, CHCH3),  1.11 (d, J = 7.2 Hz, 3H, CH3).  13C NMR (300 MHz, 
CDCl3) δ 200.7, 178.8, 160.6, 134.1, 132.9, 130.4 (2C), 128.9 (2C), 128.3 (2C), 128.0 (2C), 
127.5, 125.5, 77.3, 46.1, 41.5, 34.7, 15.5; HRMS (EI) exact mass calcd for (C20H19NO3) 
requires m/z 321.1365, found m/z 321.1377;  [αD] = 149.8 (c = 1.6, CHCl3). 
 
(R)-3-((S)-4-benzyl-2-(trifluoromethyl)-4,5-dihydro-5-oxooxazol-4-yl)butanal. 
Prepared according to the general procedure with 4 (14.3 mg, 0.05 mmol), TCA (0.05 
mmol), (E)-crotonaldehyde (124 µL, 1.5 mmol), and 4-benzyl-2-trifluoromethyl-5-
triisopropylsilanyloxy-oxazole (0.200 g, 0.50 mmol) to afford the title compound as a 
colorless oil in 78% yield (0.39 mmol) after chromatography on iatrobeads (2-5-8% 
EtOAc/hex); 9:1 syn:anti, 97% ee.  Product ratios were determined by GLC.  IR (film) 3032, 
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2970, 1815, 1725, 1656, 970, 701 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.82 (dd, J = 1.2, 2.1 
Hz, 1H, CHO), 7.81 (m, 2H, ArH), 7.53 (m, 1H, ArH), 7.42 (m, 2H, ArH), 7.17 (m, 5H, 
CH2ArH), 3.19 (q, J = 12.3 Hz, 2H, CH2Ar),  2.82 (m, 2H, CH2CHO), 2.52 (ddd, J = 2.2, 
9.4, 17.9 Hz, 1H, CHCH3),  1.11 (d, J = 7.2 Hz, 3H, CH3).  13C NMR (300 MHz, CDCl3) δ 
200.7, 178.8, 160.6, 134.1, 132.9, 130.4 (2C), 128.9 (2C), 128.3 (2C), 128.0 (2C), 127.5, 
125.5, 77.3, 46.1, 41.5, 34.7, 15.5; HRMS (EI) exact mass calcd for (C20H19NO3) requires 
m/z 321.1365, found m/z 321.1377;  [αD] = 149.8 (c = 1.6, CHCl3). 
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Chapter 3 
Enantioselective Organo-Cascade Catalysis:  
Electrophilic and Nucleophilic Activation by One Amine Catalyst 
 
Introduction 
Traditionally, a complex target is synthesized step-by-step, using a different 
combination of reagents and catalysts for each transformation.  An idealized synthesis 
would involve combining all achiral building blocks at the beginning, adding a single 
compound that could catalyze every reaction, and isolating a single isomer of pure product.  
Much effort has been channeled recently into the development of so-called “domino,” 
“cascade,” and “tandem” reactions.  Herein is described the use of a single imidazolidinone 
which participates in both nucleophilic iminium catalysis and electrophilic enamine 
catalysis.1,2  This chiral amine catalyzes the enantioselective reaction of achiral starting 
materials to selectively connect multiple stereocenters across the newly formed bonds. 
In biological systems, various enzymes will catalyze a string of reactions to build 
molecular complexity.  Rather than the traditional reaction by reaction mode of chemical 
synthesis, it seemed possible that the appropriate chiral catalysts could be found which 
could co-exist in the same environment without reacting with each other but which would 
react rapidly and selectively with their particular substrates in analogy to these enzymatic 
systems.   
 
 
A.  Concurrent Tandem Reactions with Chiral Imidazolidinone Catalysts 
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The organocatalytic mechanism heretofore described (Chapters I and II) has been the 
LUMO-lowering activation of an α,β-unsaturated aldehyde electrophile towards 
nucleophilic attack (Scheme 1, eq. 1).1  We have also shown that the first-generation 
imidazolidinone catalyst is also capable of the HOMO-raising activation of a saturated 
aldehyde to react as a nucleophile towards an electrophile (Scheme 1, eq. 2).2e  Considering 
the fact that nucleophilic attack on an unsaturated aldehyde produces a saturated aldehyde, 
it should be feasible to start with an α-β-unsaturated aldehyde and add a nucleophile at the 
β-position and an electrophile at the α-position by joining together these two modes of 
activation. 
Scheme 1.  Linking iminium (Im) and enamine (En) organocatalysis 
(1)
(2)
(3)
•HX
•HX
chiral amine catalyst
= HNR2
 
The proposed linking of two separate catalytic cycles to carry out these transformations 
is shown in Figure 1.  The single catalyst at the center of the figure operates through both 
cycles.  In the first cycle, condensation with the unsaturated aldehyde forms an α,β-
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unsaturated iminium, which the nucleophile (Nu) attacks.  After tautomerization, hydrolysis 
liberates the saturated aldehyde bearing the pendant nucleophile.  In the second cycle, this 
saturated aldehyde condenses to again form an iminium, which tautomerizes to the enamine 
that traps the electrophile (E).  The iminium formed upon electrophilic attack is hydrolyzed 
to yield the desired tandem product and regenerate the chiral amine catalyst. 
Figure 1.  Merging LUMO-lowering and HOMO-raising iminium and enamine catalysis 
N
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trapping
 
It is important to note that upon iminium formation in the first cycle, the R group on the 
achiral enal is positioned away from the tert-butyl group and under the aryl moiety of the 
imidazolidinone catalyst.  Thus, the catalyst forces the nucleophile to approach from the 
bottom face, opposite the shielding aryl group.  In the second cycle, the stereochemical bias 
due to the chiral center now at the γ-position of the enamine could run contrary to the 
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selectivity imposed by the catalyst.  Therefore, the selectivity of such a tandem reaction 
requires that the catalyst control in the second cycle eclipse by far any substrate effects. 
A variety of heterocycles have proved successful in the LUMO-lowering catalyzed 
conjugate addition to enals, including furans, indoles, and thiophenes.1  α-Chlorination was 
chosen as the second step as perchlorinated quinone 1 was expected to be compatible with 
the entire range of nucleophiles utilized in enantioselective carbon-carbon bond forming 
conjugate addition reactions.2e  Exposure of the chiral, activated nucleophile formed upon 
heterocycle addition with an electrophile such as chlorinating agent 1,13 would provide an 
α-chloroaldehyde with a vicinal tertiary carbon stereocenter in one step.  
Catalyst structure is critical to the success of this 3-component coupling (Table 1).  
Whereas amine catalyst 2 was our original catalyst reported for the organocatalytic α-
chlorination of aldehydes, it provides only trace amounts of desired tandem product (8).  
Tert-butyl imidazolidinone catalysts 3-5 efficiently catalyze the tandem 
addition/chlorination to form furyl α-chloroaldehyde 8 (entries 2-4, 97-98% ee, 78-79% 
conv.), with amine 5 inducing a high 11:1 dr.  Glycine-derived imidazolidinone 61c 
performs poorly for these substrates but outperforms the N-benzyl indole catalyst (4) for 
certain non-aromatic tandem products (entry 5, 89% ee, 10% conv.).  Although successful 
for numerous reactions involving enamine catalysis, proline (7) does not provide any 
tandem product (entry 6).2b,c 
 
Table 1.  Catalyst dependence of tandem conjugate addition/α-chlorination 
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entry conv (%)a % eea
1
2
3
4
5
3
79
78
78
88
97
97
98
chiral amine syn:antia
1:1.4
8.7:1
8.1:1
11.0:1
20 mol% catalyst 
20 mol% TFA
2.0 eq. 1, EtOAc
 –40 oC, 20 h
O
Me
Cl
OMe
N
H
CO2Me
6
10
0
894.7:1
ND ND
N
H
N
Me O
Bn
N
Me
Me
Me
N
N
H
OMe
Me
Me
Ph
N
N
H
OMe
Me
Me
Me
Ph
N
H
N
Me O
H
N
Me
Me
Me
N
N
H
OMe
Me
Me
Me
O
Me
catalyst #
2
3
4
5
6
7
O
Cl
Cl
Cl
Cl
Cl
Cl
1
O
Me
83 eq.1 eq.
 
aProduct ratios determined by chiral GLC with internal standard. 
Dr. Yong Huang explored the scope of this tandem addition/chlorination process with 
aromatic nucleophiles and found that the conjugate addition of indoles, furans, and 
thiophenes in tandem with chlorination was highly selective for a range of α,β-unsaturated 
aldehydes (99% ee, 67-87% yield, 9:1-22:1 syn:anti dr).   
The focus herein is on substrates in which a stereocenter is also formed on the 
nucleophile.  One of the first nucleophiles analyzed was 4-methyl silanyloxy oxazole 10 (II-
A).  Interestingly, indole substituted catalyst (4), which is the optimal catalyst for the 
conjugate addition of 10 to α,β-unsaturated aldehydes, was not found to be efficient in the 
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tandem addition/chlorination reaction.  While tert-butyl N-benzyl indole imidazolidinone 
catalyst 5 provides high enantioselectivity under a range of conditions (93-97% ee), only 
the reaction conducted in ethyl acetate (EtOAc) provided useful levels of tandem product in 
less than a day (Table 2, entry 5).  On the other hand, catalyst 6 provides good conversion 
with both TCA and TFA as co-catalysts and with CH3CN and acetone as solvents in 99% 
enantioselectivity in 8 hours at –40 °C (entries 9, 10, 12, and 13). 
Table 2.  Optimization of reaction conditions for oxazole addition/chlorination 
TIPSO
Ph
N
O
Me
Me O
N
O
O
Ph
Me
Me
CHO
Cl
10 mol% catalyst 5 or 6
10 mol% HX
2.0 eq. 1, 1 eq. H2O
solvent, –40 °C
1.0 eq. 3.0 eq.
TCA
TFA
TCA
TFA
EtOAc
CH3CN
acetone
EtOAc
EtOAc
CH3CN
acetone
EtOAc
CH3CN
acetone
EtOAc
CH3CN
acetone
11
7
15
56
74
13
7
48
100
79
55
98
83
7
7
7
7
22
7
7
8
8
8
8
8
8
9:1
9:1
8:1
6:1
10:1
8:1
7:1
10:1
9:1
9:1
6:1
7:1
7:1
95
93
94
97
96
96
96
99
>99.5
98
98
99
99
1
2
3
4
5
6
7
8
9
10
11
12
13
entry conv. (%) ee (%)HX time (h) drsolvent
10
5
5
5
5
5
5
5
6
6
6
6
6
6
catalyst
 
One of the few β,β-disubstituted enals that provides desired product in the tandem 
hydrogen transfer/chlorination reaction is γ-silyloxy substituted enal 11.  The reduction is 
carried out with as little as 1.2 equivalents of the Hantzsch reducing agent, but in 
accordance with our earlier report1c of the catalytic asymmetric hydrogenation of enals, the 
use of imidazolidinone catalyst 6 is also required.  One of the main issues with this reaction 
is the presence of two byproducts, the diester substituted pyridine from the Hantzsch and 
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the chlorinated phenol from perchlorinated quinone 1.  In fact, with 10 mol% 6•TCA at –40 
°C, the reaction does not go to completion and becomes messy enough that an accurate 
conversion could not be gathered, and these reactions take a full 24 h even with 20 mol% 
imidazolidinone 6•TCA (Table 3). 
Table 3.  Higher catalyst loading required for tandem hydrogenation/chlorination 
O
Me
N
H
CO2EtEtO2C
MeMe
O
Me
TBDPSO
Cl
1.0 eq. 1.2 eq.
n mol% 6•TCA
2.0 eq. 1, CHCl3 
–30 or 40°C
TBDPSO
entry
1
2
3
4
conv. (%)
76
incomplete
86
84
ee (%)
96
ND
95
96
–30
–40
–30
–40
temp (°C)
11
10
10
20
20
mol% 6•TCA
 
Equation 4 shows that the tandem addition/chlorination of silylnitronate 9 and 
crotonaldehyde proceeds in 98% ee, but the major isomer and 3 minor diastereomers are 
formed in a 2:1 ratio and 73% GC yield.  Whereas amine 5 does not efficiently catalyze the 
tandem process for silanyloxy oxazole 10 (81% conv., 22 h, 96% ee, 10:1 dr), amine 6 
provides complete conversion in 8 h with 99% ee, 9:1 dr, and 75% yield of the hydrate 
upon purification with iatrobeads (Equation 5).  Tert-butyl catalyst 6 also affects the tandem 
hydrogenation1c and chlorination of aldehyde 11 in 96% ee, 8:1 dr, and 84% yield 
(Equation 6).   
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(5)
N
O
O
Ph
Me
O
Me
ClN
O
OTIPS
Me
Ph
OMe
10 mol% 6•TCA, 2 eq. 1
CH3CN, 1 eq. H2O, –40 °C
1.0 eq. 3.0 eq. 99% ee, 9:1 dr
75% yield, 8 h
TESO
N
O
Et (4)
OMe
i) 10 mol% 5•TCA, EtOAc
   1 eq. H2O, –40 °C
ii) 2 eq. 1
1.0 eq. 3.0 eq. 98% ee, 2:1 dr
73% yield, 12 h
O
Cl
Me
Et
O2N
(6)
O
i)  20 mol% 6•TCA, CHCl3, –40 °C
ii)  2 eq. 1
1.0 eq.
1.2 eq.
96% ee, 8:1 dr
84% yield, 24 h
TBDPSO
Me
O
TBDPSO
Me
Cl
N
H
EtO2C CO2Et
MeMe
9
11
10
 
These α-chloroaldehydes are incredibly useful in that they can transmit the 
stereochemistry at chlorine to the formation of enantioenriched derivatives such as 
epoxides, aziridines, amino acids, and other important structural motifs.2e  Coupled with the 
utility of the nucleophile-derived component of the product, this asymmetric 
organocatalytic process provides swift access to novel organic scaffolds with multiple 
functional handles in high selectivity and yield.  There are catalysts which can be applied to 
multiple reactions, but these imidazolidinone catalysts are also capable of operating via 
opposing mechanisms, activation of an electrophile towards nucleophilic addition followed 
by the activation of that adduct as a nucleophile to attack an electrophile.  Our particular 
interest in new reaction manifolds has led us to new avenues of reactivity in the pursuit of 
small molecules with significant application in the synthesis of natural products and drug 
therapies.  
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Supporting Information 
 
General Information.  All solvents were used as obtained from commercial suppliers 
unless otherwise indicated.  Other commercial reagents were purified prior to use following 
the guidelines of Perrin and Armarego.11 Thin layer chromatograms (TLC) was performed 
on EM reagents 0.25 mm silica gel 60-F plates.  Visualization of the developed 
chromatogram was performed by fluorescence quenching and KMnO4 or para-anisaldehyde 
stain.  Organic solutions were concentrated under reduced pressure on a Büchi rotary 
evaporator.  Chromatographic purification of products was accomplished using forced-flow 
chromatograms on Iatrobeads or Fisher 200-425 mesh Davisil (grade 643, type 150A) 
according to the method of Still.12  
1H and 13C NMR spectra were recorded on a Varian Mercury 300 (300 MHz) instrument, 
and are internally referenced to residual protio solvent signals.  Data for 1H NMR are 
reported as chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet), coupling constant (Hz), integration, and assignment.  Data for 13C 
NMR are reported as chemical shift.  IR spectra were recorded on Perkin-Elmer Paragon 
1000 spectrometer as thin films and reported in terms of frequency of absporption.  Mass 
spectra were obtained from the California Institute of Technology Microanalytical Services 
facility.  GLC was performed on Hewlett-Packard 6850 and 6890 Series gas chromatographs 
equipped with a split-mode capillary injection system and flame ionization detectors using a 
Bodman Chiraldex Γ-TA (30 m × 0.25 mm) column. 
                                                
11 Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; Fourth ed.; Butterworth-
Heinemann:  Oxford, 1996. 
2Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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(2R,3S)-2-chloro-3-((S)-4,5-dihydro-4-methyl-5-oxo-2-phenyloxazol-4-
yl)butanal.  To a 1-dram vial equipped with a magnetic stir bar and charged with (2R)-2-
tert-butyl-3-methyl-imidazolidin-4-one TCA salt (16 mg, 0.05 mmol) and 2,3,4,5,6,6-
hexachloro-2,4-cyclohexadien-1-one (300 mg, 1.0 mmol), acetonitrile (1.0 mL) and H2O (9 
µL, 0.5 mmol) were added.  The vial was cooled immediately to –40 °C.  After 3 minutes, 
crotonaldehyde (124 µL, 1.5 mmol) and 5-triisopropylsilanyloxy-4-methyl-2-phenyloxazole 
(166 mg, 0.5 mmol) were added via syringe.  After 4 h, the reaction was flushed though an 
Iatrobeads plug with Et2O and concentrated. The title compound was isolated as the hydrate 
in 75% yield (0.1123 g, 0.38 mmol) after chromatography on Iatrobeads (0-2-4-7% 
Et2O/hex to 4:11:85 to 4:13:83 EtOAc/Et2O/hex); 9:1 syn:anti, 99% ee.  Product ratios were 
determined by GLC (Bodman Γ-TA column, 140 °C, 20 min; 1 °C/min gradient, 145 °C, 20 
min; 1 °C/min gradient, 150 °C, 20 min 23 psi); (2R, 3S) syn isomer tr =  59.9 min, (2S, 3R) 
syn isomer tr =  62.7 min, anti isomers t = 64.0 min.  IR (film) 3045, 2939, 1822, 1724, 
1654, 1004 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.76 (m, 2H, ArH), 7.43 (m, 3H, ArH), 5.26 
(d, J = 4.1 Hz, 1H, CH(OH)2, 4.34 (dd, J = 4.1, 9.2 Hz, 1H, CHCl), 2.77 (m, 1H, CHCH3), 
2.06 (s, 3H, CH3), 1.40 (d, J = 7.2 Hz, 3H, CHCH3).  13C NMR (300 MHz, CDCl3) δ 202.8, 
182.7, 163.6, 135.0, 131.2, 128.5, 128.0, 82.1, 70.2, 62.4, 48.3, 23.3, 11.2; HRMS (FAB) 
exact mass calcd for (C14H15ClNO3) requires m/z 280.0744, found m/z 280.0744;  [αD] = –
2.1 (c = 1.0, CHCl3). 
 
 
 
